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Abstract
Following the Gulf War there were many concerns raised about human exposure to
chemicals and how these chemicals may affect the body. When a soldier deploys to a
foreign country during times of conflict, there will be stress related changes in his or her
body. Stress causes several changes in basic functions of a human body, from breathing
and blood flow changes to hormonal and enzyme changes, and increased permeability of
the blood-brain barrier. Each of these changes can strongly influence chemical uptake,
distribution, and accumulation in the body.
The purpose of this thesis was to model and predict the changes that will occur when
stress is combined with chemical exposure. Physiologically-based pharmacokinetic
(PBPK) modeling is one tool that can be used to visualize, predict, and generate a
hypothesis about chemical exposures. A PBPK model was developed that simulated
human tissue compartments during chemical exposure and different levels of exercise.
As a result of a conceptualization, formulation, and testing stage it appears that this
PBPK model is a valid tool for helping explain and predict the fate and transport of a
chemical on an individual under stress. The results suggest that the brain compartment is
of high importance when addressing the uptake of chemicals during exercise. The
maximal uptake of a chemical from the blood-brain barrier, as well as the decreased
enzymatic levels in the brain compartment have been identified as key parameters for
further study. The model developed is a simple tool that can be applied to future
exploration.

IX

A PHARMACOKINETIC STUDY OF THE EFFECTS OF STRESS ON
CHEMICAL EXPOSURE

I. Introduction

Background
The word "stress" is derived from the Latin verb strictus, meaning to draw tight.
The modern definition of stress, in the context of this thesis, originates from its use in
physics where stress describes an applied force or system of forces that tend to strain or
deform a body (The American Heritage College Dictionary, 1993:1343).
The concept of stress was introduced into the biomedical field by Canadian
physiologist Hans Selye in the 1930's and stress soon became a recognized field of study
(Opstad, 1995:9). Selye referred to stress as the nonspecific response of the body to any
pressure that is vital to survival (Selye, 1976:35). Selye used the term nonspecific to
describe stress due to the fact that the body will adapt to a given pressure irrespective of
the problem (Fox, 1996:291). Stress prepares the body for any stressful situation by
releasing a specific chemical response, also known as the "fight or flight" response
(Gherman, 1981:9). The release of epinephrine and norepinephrine into the bloodstream
and the resulting excitatory or inhibitory effects on various organs, such as increased
heart rate and ventilation, are the most common observations during a stressful situation.

Stress can result from a wide range of internal or external Stressors. A Stressor
can be defined as any perturbation that disrupts homeostasis (Sapolsky, 1992:3). These
Stressors can vary in many ways and impact the body along several different pathways.
To make the matter more complicated Stressors can also act differently on each human
body (Gherman, 1981:4). External Stressors require some sort of adjustment to a new set
of external conditions, while internal Stressors result from the internal demands that
individuals may put on themselves (Gherman, 1981:6). Humans are equipped to deal
with these Stressors, but when these Stressors trigger the stress response repeatedly, the
effects begin to multiply and compound Over a lifetime. Increased duration and intensity
of Stressors can cause several stress-related diseases to emerge (Sapolsky, 1992:6).
The long-term implications of chronic stress and the addition of chemical
exposure have seen greater attention recently due to the Gulf War Syndrome. In past
years, there have been many concerns raised about human exposure to chemicals and
how these chemicals affect the body. When a soldier deploys to a foreign country during
times of conflict there will be changes in his or her body. Stress may cause several
changes in basic functions of the human body, from breathing and blood flow changes to
hormonal and enzyme alterations. When under stress, the body's response to chemical
exposure may be different than the response not under stress. This addition of stress may
lead to an exaggerated negative response to chemical exposure. Recent human and
animal studies have suggested specific physiological changes under stress. A number of
these changes are known to strongly influence chemical uptake, distribution, and
accumulation in the human body.

At the close of the Persian Gulf War in 1991, many soldiers returned home with a
wide range of health complaints. These symptoms ranged from headaches and fatigue to
memory loss and depression, and were collectively called the Gulf War Syndrome. In the
eight years since the war there have been reports of approximately 100,000 of the
697,000 U.S. veterans displaying these symptoms, and most of these veterans attribute
symptoms to the war (Haley, 1997:695). Prompted by the seriousness of the
implications, the U.S. Department of Defense (DOD) formed a Presidential Advisory
Committee on Gulf War Veterans' Illnesses and conducted an $80 million evaluation of
the long-term health problems observed in soldiers who served in the Persian Gulf War
(Pennisi, 1996:479). The Committee failed to identify a specific disease that could
explain the symptoms or a specific cause, but they did attribute the variety of ailments to
wartime stress (Haley, 1997:695). The main argument for stress as the cause of the Gulf
War Syndrome was based on several studies of post-traumatic stress disorder (PTSD) in
Gulf War Veterans (Haley, 1997:695).
Many veterans have rejected the suggestion that stress plays an important role in
the Gulf War Syndrome, while several other studies have pointed to other explanations.
Diseases behind the syndrome have included conditions such as chronic fatigue
syndrome and multiple chemical sensitivity. Possible exposure to agents such as
depleted uranium, insecticides, anti-nerve agents, and smoke from oil-well fires have also
been investigated (Wegman, 1997:704). It is unlikely that any one of these theories will
provide a unified explanation for the syndrome. However, studies have discussed the
possible combinations of wartime stress and chemical exposure. Several animal studies
in particular have shown that stress-induced changes in the body can disrupt the blood-

brain barrier. Disruption in the blood-brain barrier may allow chemicals, such as
pyridostigmine bromide, to penetrate the brain due to an increased permeability and
produce potentially damaging long-term consequences. Pyridostigmine bromide was
administered to soldiers during the Gulf War as a pretreatment against chemical warfare
(Friedman, 1996:1382). Future studies that focus on the changes in the permeability of
the blood-brain barrier could aid in understanding the mechanisms behind stress and how
environmental or occupational stress may actually play a role in the Gulf War Syndrome.
The search for explanations of the Gulf War Syndrome has created a need to
protect military personnel from toxic and hazardous chemicals and practice preventive
medicine, including the identification of environmental and occupational Stressors. This
new field of study is called deployment toxicology. Military personnel will face a
growing number of threats in the operational environment in future years. Conflict
prevention, humanitarian relief, and peacekeeping activities will require that military
personnel enter areas where there will be an increased threat to human health and
performance will become more prevalent. DOD Directive 6490.2 now ensures that each
branch of the military conducts medical surveillance during military deployments. This
will include developing a system to more rapidly forecast and assess risks that may be
encountered before, during, and after deployments.

Problem Statement
An understanding of the etiology behind the Gulf War Syndrome will help fill the
major gaps that have hindered the studies and immediate identification of the disease.
The lack of objective data on environmental exposures and the lack of understanding the

mechanisms behind the behavior of a chemical in the human body are two deficiencies
that are in need of further research (Jollenbeck, 1998:71). A better understanding of the
mechanisms of stress and chemical exposure in the human body could help prevent future
Gulf War Syndromes and aid in the development of deployment toxicology practices.

Purpose Statement
The purpose of this thesis is to model and predict the changes that will occur
when stress is combined with chemical exposure. Physiologically-based pharmacokinetic
(PBPK) modeling is one tool that can be used to visualize, predict, and generate a
hypothesis about chemical exposures. This thesis effort will be directed towards
understanding the concepts behind stress and chemical exposure, and then developing an
initial PBPK model. The model will study internal interactions of the complex human
body, investigate the effects of external Stressors on the system behavior, and explore
different scenarios of stress and chemical exposure to help understand system behavior
under varying system conditions.
Understanding the responses that stress will solicit in the human body during
chemical exposure will be very important in trying to prevent adverse effects, as well as
aid in the performance of an individual. The model developed in this thesis will help
predict the distribution of any chemical in an individual who is under a high degree of
stress. The model developed will be a tool that can be used and applied to future
exploration. This study may be one of the first steps in understanding stress and chemical
distributions in the body. This may allow us to predict the influence of stress during
wartime on chemical effects to the body.

Research Objectives
In order to develop a general model for predicting stress and chemical
distributions in the human body as they relate to stress, there are four research objectives
that are accomplished:
1. Determine the mechanisms of stress and chemical uptake/distribution in the human
body.
2. Use the principles of system dynamics modeling to better understand the influences
of stress on chemical uptake and distribution.
3. Through testing of a PBPK model support the hypothesis that stress will affect
chemical concentrations in the human body.
4. Establish a framework for ongoing investigation of chemical exposure as modified by
deployment and stress.

II. Literature Review

The purpose of this literature review is to present relevant literature background
on the subjects of stress and chemical exposure. In order to emphasize this need, the
following chapter has been organized with the four research objectives in mind. The first
section will discuss the mechanisms of stress in the human body. Second, the literature
and theories behind the Gulf War Syndrome will be presented. Third, literature on
chemical exposure and distribution will be presented. Finally, a review of the use and
capabilities of system dynamics and PBPK modeling as previously used in the study of
chemical exposure will be discussed.

Mechanisms of Stress in the Human Body
Stress, as defined in the introduction, is the nonspecific response of the body to
any pressure. Hans Selye felt that this nonspecific response was used in the body to
readjust itself following any perceived imbalance or threatened disruption of homeostasis
(Fox, 1996:291). Selye found that a stereotyped syndrome can be induced in rats when
exposed to heat, cold, infection, trauma, and many other stimuli or Stressors. This
syndrome was referred to as the general adaptation syndrome (GAS). There are three
stages in the GAS: 1) Alarm reaction - the activation of the adrenal glands and increased
secretion of corticoid and epinephrine occur; 2) Stage of resistance - the body adapts to
the Stressor and readjustment occurs; and 3) Stage of exhaustion - exhaustion will occur if
the body is not able to completely readjust to the Stressor. These Stressors can range from

acute to chronic or mild to severe and will have different effects in each individual
(Cooper, 1983:6).
Selye's concept of stress has evolved over the years to include the specific
mechanisms of the endocrine and nervous systems. It was found during stress
experiments on rats that nervous stimulation caused a stress response, but denervated rats
also showed the same response when stressed; this lead to the discovery of hormones
(Cooper, 1983:6). A hormone is a regulatory molecule that is secreted into the blood by
several organs in the endocrine system (Fox, 1996:272). The release of hormones
follows a set chain of events that cause the specific changes in the body - the changes
seen in Selye's GAS. This chain of events is controlled through positive or negative
feedback loops via the hypothalamus-pituitary axis (Cooper, 1983:8). Figure 1 is a
simplified graphic representation of the stress response in the human body.
The following sequence is an overview of the release of hormones and the
interactions of the endocrine and nervous system, as seen in Figure 1 (Ghermart,
1981:148-150):
1. A stressful event will produce a physiological and emotional response in the body.
These responses trigger the initial release of endorphins, releasing or inhibiting
hormones, from the hypothalamus.
2. Endorphins trigger the body's pituitary gland causing a release of
adrenocorticotrophic hormone (ACTH) into the bloodstream. ACTH then travels on
to the adrenal glands.
3. The external portion of the adrenal gland (adrenal cortex) secretes steroid hormones
called corticoids, mainly glucocorticoids, such as cortisol or corticosterone. These

hormones are responsible for preparing the body for the adaptive reactions that take
place due to a Stressor. Corticoids facilitate enzyme reactions and affect immune
reactions.
4. The inner part of the adrenal gland (adrenal medulla) receives a nerve impulse from
the hypothalamus and immediately secretes epinephrine, also known as adrenaline,
into the body. This specific sequence involving the adrenal medulla is referred to as
the "fight or flight" or sympathetic response. Increased metabolic or cardiovascular
activities such as increased alertness, increased physical strength, increased heart rate,
increased blood flow, and faster breathing are the common results of an increased
release of epinephrine. When an individual is exposed to chronic or intense stress the
secretion of epinephrine will prolong the sympathetic response and a continual stream
of corticoids are released from the adrenal cortex.
5. This in turn will stimulate the liver to release more blood glucose to supply extra
energy for recovery. This process of releasing blood glucose from the liver is called
gluconeogenesis. Gluconeogenesis causes the mobilization of fats and proteins into
the blood.
This fifth event is the point where the continuation of exposure to a chronic or
intense stress will produce damaging effects in the body. Overactivation of the stress
response or the inability to terminate the secretion of hormones can result from a
prolonged stress. It was found during several studies that prolonged stress would result
in muscular wasting and impairment of the immune system by depletion of protein stores
in the body. These protein stores are needed for development of white blood cells and
antibodies. Prolonged stress also results in a high level of fat in the bloodstream due to

the gluconeogenesis process; which may enhance the risk of arteriosclerosis.
Furthermore, the release of fats and proteins into the bloodstream decreases the use of
glucose in the system resulting in an excess amount of glucose, which can then lead to
diabetes (Gherman, 1981:150).

*
Nerve Impulse

Stressor
(Endorphines)
►•

Hypothalmus

(Epinephrine)
Pituitary Gland

Adrenal Medulla
"Fight or Flight
Response"

(ACTH)

''
Adrenal cortex

(Blood Glucose)

(Corticoids)

_

-^

Liver

Damaging effects of chronic stress:
1. Muscular wasting
2. Immune system impaired
3. Increased fat in the blood
4. Decreased use of glucose in system

Figure 1. Stress Response in the Human Body

The results of stress can impact every part of the body. Stress is known to affect
the cardiovascular, endocrine, immune, and central nervous system (Gherman,
1981:150). Stress and disease are interconnected in that every disease causes a certain
type of stress, while stress plays a role in the development of disease. Stressors can
disrupt the body's homeostasis by either going beyond the body's ability to adapt or by
causing damage due to a particular weakness (Cooper, 1983:12). This is why every
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individual is different in responding to stress. Due to heredity or external influences each
individual will have a unique weakness. This has made the study of stress very difficult
due to the fact that humans develop different diseases or symptoms under the influence of
the same kind of Stressor (Cooper, 1983:13).
A large amount of recent research has focused on the differences in stress
response among various individuals. Studies suggest that people fall into different
categories of responses when dealing with stress. In one particular study, men were
subjected to five days of arithmetic tests. Cortisol concentrations were tested each day.
Two different groupings of cortisol levels appeared with one group having a higher level
than the other. The men categorized in the higher cortisol group also reported more
health problems, and had larger variations in heart rate when under stress (Sgoutas-Emch,
1994:264).
Other studies have looked at the differences between men and women's response
to stress. Women's blood pressure goes up less than men's blood pressure in response to
stress, but women tend to react to a larger range of Stressors. And finally, it has been
found that childhood stress is on the rise. Research has found that childhood experiences
with exposure to stress have a great influence on how adults deal with stress (Kalb,
1999:62).
Psychologist Sheldon Cohen completed the study that found an association
between stress and reduced immune response in 1991. Individuals who ranked higher on
a test of perceived stress were also more likely to develop colds. Cohen also found that
chronic stress can increase the odds of getting sick by three to five times (Cohen,
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1998:214). Everyday stresses accumulate and have a greater impact on the human body
than just one isolated stressful event (Brosschot, 1994:216).
Another study performed by Zakowski and others found reduced antibody levels
among individuals caring for spouses suffering from dementia. This study and several
others have found that stress causes either an increase or decrease in the levels of natural
killer (NK) cells, an increase in killer T-cells (CD8), and a decrease in helper T-cells
(CD4) (Zakowski, 1992; Kiecolt-Glaser, 1992; Delahanty, 1996; and Shephard, 1998).
These changes affect the human body's ability to regulate and enhance immune
functions.
Shephard and others have performed numerous tests on military personnel during
periods of physical stress or exposure to adverse environmental conditions. Results show
that immune systems were more vulnerable, and a high incidence of "performanceimpairing infections" developed (Shephard, 1998:545). Several other experiments have
found that tumors will grow faster in animals subjected to stress, which is again related to
corticoid levels (Fox, 1996:448). The strength of the immune system is also affected by
stress in cancer progression studies done in humans (Delahanty, 1996:48).
Robert Sapolsky has researched several issues on the effects of stress. Sapolsky
found that corticoids that are secreted in excess are damaging to the human brain.
Corticoids, which are released from the adrenal cortex, have a large role in stimulating
the hippocampus, an organ vital for memory and learning. Researchers have found that
an excess secretion of corticoids, as is the case with depression or Cushing's syndrome
patients, can actually damage the hippocampus. Memory and cognitive abilities are
impaired, and significant reductions in the volume of the hippocampus appear in
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magnetic resonance imaging (MRI) scans (Sapolsky, 1996:749). Studies of patients with
posttraumatic stress disorder (PTSD) have also supported the evidence of the relation
between corticoids and hippocampus size and function. Bremner and others found 12%
atrophy in the hippocampus of adults with PTSD who were subject to childhood abuse.
Bremner also found similar results in Vietnam veterans with PTSD. The veterans had
8% hippocampal atrophy. Longer periods of combat exposure in the veterans were
associated with a smaller hippocampus (Sapolsky, 1996:749).
Sapolsky and Kaufer have also studied the relations between stress and a reduced
level of acetylcholine (ACh) and cholinergic neuron expression (Kaufer, 1998:373).
ACh is an excitatory or inhibitory neurotransmitter chemical that communicates from a
neuron to another neuron, a muscle, or a gland. ACh is inactivated by
acetylcholinesterase (AChE). AChE is vital in deactivating the nerve conduction
performed by ACh (Fox, 1996:157). Kaufer and others found that a forced swim stress
exposure on rats elicits two separate phases. The stress exposure was found to have the
same affect as AChE inhibitors, which first results in an increase in excitatory ACh.
After the Stressor occurred, an unknown second phase was discovered where decreased
neuron excitability (or increased AChE) and impaired cognition occur (Kaufer,
1998:373). Kaufer found that levels of AChE were still elevated eighty hours after the
end of the swim Stressor performed on the rats. This negative-feedback loop that results
in impaired cognitive ability is a very important step in stress research, and also leads to
questions of the possible synergistic effect of both stress and AChE inhibitors (Sapolsky,
1998:309).
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Gulf War Syndrome
Between August of 1990 and July of 1991, approximately 697,000 U.S. military
personnel served in the Persian Gulf during Operations Desert Shield and Desert Storm.
For a significant portion of these individuals, the Persian Gulf experience was
psychologically stressful - before, during, and after the deployments. The war-related
environment has historically been associated with a wide range of Stressors (Hyams,
1996:1). These Stressors can range from the stress of combat or fear of attack to the
stress of separation from family, long work hours, poor living conditions and different
climate conditions. In many previous wars, physical and psychological stresses have
been observed to lead to high rates of psychiatric illnesses. Disease, shell shock, combat
fatigue, chronic fatigue syndrome (CFS) and posttraumatic disorder (PTSD) are just a
few of the illnesses found to be more prevalent in combat veterans than in the general
population (Hyams, 1996:1). PTSD and depression are found in a larger majority of Gulf
War combat veterans (PAC, 1996:Ch. 3, 8).
Since the war an increasing number of veterans have complained of several
neurocognitive symptoms, which have been collectively called the Gulf War Syndrome
(Sapolsky, 1998:308). In 1996, the final report from the Presidential Advisory
Committee (PAC) on Gulf War Veterans' Illnesses concluded that collecting exposure
data and information on the risk factors in the Gulf War had been difficult, and most
information available was based on recollections of Gulf War veterans (PAC, 1996:Ch.4,
1). Therefore, it has been difficult to link the syndrome to specific exposures or risk
factors. The PAC focused on pesticides, chemical warfare agents, biological warfare
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agents, vaccines, pyridostigmine bromide, infectious disease, depleted uranium, oil-well
fire smoke, petroleum products, and psychological and physiological stress as the main
risk factors (PAC, 1996:Ch. 4,1). The PAC concluded that the collection of symptoms
seen in Gulf War veterans can be attributed to the combinations of wartime stress and the
possible exposure to variable risk factors, such as those listed above (Wickelgren,
1997:1404). It was also concluded by experts at the 1994 National Institutes of Health
Technical Assessment Workshop on the Persian Gulf Experience and Health that "no
single disease or syndrome is apparent, but rather multiple illnesses with overlapping
symptoms and causes" (New Persian Gulf Possibilities, 1996:820).
Possible Chemical Exposures during the Gulf War
Due to the recommendations made in the PAC's final report numerous
research projects have focused on chemical exposure and stress. Is the Gulf War
Syndrome in some way tied to the psychological Stressors that a soldier may be exposed
to during times of deployment? Is the Gulf War Syndrome a result of chemical
exposures? Or can the combination of stress and chemical exposure both be the culprit
behind the syndrome? These questions and the growing concern from the public have led
to several studies in pursuit of the cause behind the Gulf War Syndrome.
Four chemicals in particular have become the focus of research on the Gulf War
Syndrome. Military personnel throughout the war used DEET, permethrin,
pyridostigmine bromide, and organophosphate. These chemicals have also been the
subjects of several studies addressing their potential toxicological impacts.
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DEET
N,N-diethyl-m-toluamide, more commonly known as DEET, is an insect repellent
that has been widely used both commercially and in the military. DEET is the active
ingredient in commercial products such as Deep Woods Off and Cutter Insect Repellent.
Several formulations and various concentrations of this insecticide exist including
impregnated towlettes, solid sticks, liquids, and gels (Nelson, 1995:43). The most
common formulations used by military personnel in the U.S. Army include 75% DEET
liquid solution in ethanol, 33% DEET for extended duration formulation, and a 19%
DEET stick (McCain, 1997:115). DEET is an EPA-approved insect repellent and has
been linked with low levels of toxicity in animal studies (McCain and others, 1997:114).
DEET crosses the blood-brain barrier, and neurotoxic damage has been reported
(Verschoyle and others, 1992:80). Human health effects from exposure to DEET
include: slowed respiration, slowed pulse rate, low blood pressure, depression, tremors,
convulsions, skin rash, necrosis, and blistering (Nelson, 1995:39). The rat oral LD50 of
DEET is 2-3 g/kg, the dermal LD50 is 5 g/kg, and the median lethal dose is 3.67 g/kg
(Leach and others, 1988, and McCain and others, 1997).
Permethrin
Permethrin, a synthetic pyrethroid, is also an EPA-approved insecticide. The
compound is used to impregnate battle dress uniforms. Most uses of this insecticide
during the war were in the form of 0.5% aerosol spray, which provides protection for up
to six washings or six weeks of wear (McCain and others, 1997:115). Wester and others
found that insecticides impregnated in fabric could still be absorbed into the skin and then
into the systems of the human body. The addition of water or other solvents to simulate
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sweating or wet conditions caused an increase in skin absorption (Wester and others,
1996:734). Permethrin readily crosses the blood-brain barrier and acts upon transport
mechanisms in the brain tissue. The median lethal dose in rats for permethrin is 1000
mg/kg (McCain and others, 1997:119).
Pyriodostigmine Bromide
Pyridostigmine Bromide (PB) is a quaternary ammonium carbamate that was used
as a pretreatment against nerve agents during the GulfWar due to its ability to inhibit
acetylcholinesterase (AChE) (McCain, 1997:115). PB used alone is not protective
against nerve agent poisoning but must be used as a pre-treatment to counter the effects
of atropine used by military forces. PB actually competes for binding sites of AChE.
The key to PB's success is that instead of the irreversible bond that nerve agents have
with AChE, PB has a reversible bond. PB's bond to AChE will detach more quickly,
leading to reactivation of AChE and normal functioning (Cook and others, 1992:250).
The quaternary structure prevents PB's permeation through the blood-brain barrier
(Freidman, 1996:1382). The median lethal dose for PB lies in the range of 60 to 80
mg/kg (McCain and others, 1997:119). The LD50 of PB is 2.73 mg/kg (Blick and others,
1994:312). In 1995, the Food and Drug Administration (FDA) initially approved PB for
treatment of myasthenia gravis (MG), a chronic neuromuscular disease (Fox, 1996:164).
Based on the evidence that PB was safe when used as a drug with MG patients, the FDA
concluded that PB was also safe for use by U.S. military personnel. MG patients
typically take 1500 mg per day over several years, while military personnel take 90 mg
per day over a maximum of seven days. The DOD estimated that approximately 250,000
military personnel took PB at some time during the war. Side effects of PB include

17

nausea, vomiting, dizziness, muscle weakness, and abdominal cramps. As with MG
patients, the side effects of PB found in a DOD study ceased when PB use was
discontinued. After several research efforts, the DOD has concluded that PB alone has
no serious or long-term reactions (PAC, 1996:Ch. 4,17).
Organophosphates
Many suspect exposures to organophosphates (OP) as a possible factor behind the
symptoms found in the Gulf War Syndrome. The concern over OP exposure surfaced in
the 1960's when farmers and industrial workers experienced memory and concentration
problems after chronic occupational exposure of low levels of OP. Similar symptoms are
now being found in Gulf War veterans. Several OP pesticides were used during the war
to include diazinon and malathion (PAC, 1996:Ch. 4, 7). Buccafusco and colleagues
have found in rat models that low levels of OP produce long term problems in the brain
(Wickelgren, 1997:1404). Buccafusco found that OP reduced the number of receptors in
the hippocampus region of the brain in rats, which hinders the response to nerve
impulses. The rats also developed learning disorders that persisted for 3 weeks after the
last OP injection. AChE is inhibited which leads to a build up of ACh in the nerve
synapse; thus an overfiring of the nerves. High levels of OP can lead to death (LaPuma,
1999). Atropine, which blocks ACh receptors, counters the effects of OP. Atropine is
currently used by the military in an auto-injector if personnel are exposed to nerve gas
(LaPuma, 1999). Studies, such as the one performed by Buccafusco, now raises the
concern over low level exposures of OP to military personnel.
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Gulf War Related Research
Several areas of research conducted on the Gulf War Syndrome are relevant to the
work presented in this thesis. Research on multiple chemical exposures, stress, and the
blood brain barrier will be discussed.
Multiple Chemical Exposure
The need for more research into the toxicity of multiple chemical exposures has
been emphasized after the Gulf War. Abou-Donia and others have found that exposure to
two or more chemicals or drugs used by military personnel during the Gulf War have
caused a synergistic type of effect in the nervous system of chickens (Abou-Donia and
others, 1996:35). The researchers exposed chickens to DEET and permethrin as well as
the anti-nerve agent called pyridostigmine bromide (PB) individually and in combination.
Results showed that neurotoxicity was greater than what was expected with individual
exposures. The compounds resulted in minimum toxicity when administered
individually, but when combined adverse neurological effects occurred. Abou-Donia and
others hypothesize that an exposure to multiple chemicals may have overwhelmed the
animals' ability to break down chemicals through enzyme interactions. In particular, PB
was found to bind to the enzyme butyrylcholinesterase. This enzyme neutralizes
nitrogen-containing organic compounds, such as DEET, permethrin, and PB. PB can
compete for butyrylcholinesterase, allowing the other chemicals to permeate the brain
and nerves (Abou-Donia and others, 1996:52).
McCain and others also conducted experiments on the lethal interactions of
DEET, permethrin, and PB in rats. A significant reduction effect occurred in the lethality
when the chemicals were given at the same time. As in Abou-Donia's conclusions,
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McCain found that competition among the three chemicals for enzymes actually reduced
metabolism of the chemicals. Thus, there is an increased availability of chemicals to be
taken up by the brain. The resulting lethal values and neurotoxicity exceeded the
expected additive values (McCain and others, 1997:113).
Stress
Extensive literature on the topic of stress and its ability to compound neurological
insults has supported the theory that stress may contribute to the Gulf War Syndrome
(Sapolsky, 1998:309). Some researchers hypothesize that PB and stress may create
central nervous system (CNS) effects. A study performed by Sharab and others looked at
symptoms following intake of PB during the Gulf War. They found that most studies
performed on the adverse effects of PB were done in nonstressful conditions. Evaluating
soldiers during the war could lead to human data on PB and exposure to stressful
conditions, such as the threat of chemical warfare attack. A correlation was found
between PB intake and the symptoms reported by soldiers. Sharab and others
hypothesized that during a stressful situation the human body becomes more sensitive to
symptoms that may have been unnoticed in studies done during peacetime conditions
(Sharab and others, 1991:656-658). Sharab and others concluded that PB administration
during the Gulf War led to an increase in the severity of CNS symptoms seen in veterans
(Sharab and others, 1991:657).
Previous animal studies have shown that stress tests resulted in a disruption of the
blood brain barrier (BBB) (Sharma, 1991:211). Friedman reported that mice subjected to
a forced stress swim test needed only l/100th of the usual dose of PB (1.50 to .01 mg/kg)
for 50% of AChE activity to be inhibited. The stressful swim event that the mice were
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exposed to allows PB penetration into the brain (Friedman, 1996:1382). The correlation
between stress and PB-induced CNS effects was confirmed when nonstressed mice
treated with PB had no affect on CNS functioning. They concluded that compounds that
are limited in their ability to permeate the blood-brain barrier might become active in the
CNS under stressful conditions (Friedman, 1996:1384). This study supports the theory
that stress-induced changes in the blood-brain barrier increase permeability.
A concern with military personnel during wartime is decreased performance due
to the intake of specific drugs. A study performed by Cook and others looked at the
effects of PB in soldiers working in a desert environment. Small decreases in
neurotransmission after muscle contraction were found. It was also noted in their study
that PB had two effects on the body's ability to cool down. Sweating rates increased by
5% during PB administration, and the skin blood flow decreased. This impaired blood
flow may be one of the reasons why the core temperature of individuals in this particular
study increased (Cook and others, 1992:254). This also has the potential to increase the
risk of heat stress in chemical warfare gear (Arad and others, 1992:213). It was
concluded, even with the above findings, that administration of PB did not significantly
reduce performance.
As mentioned earlier in this literature review, Kaufer and others have found that
stress and AChE inhibitors, such as PB, can have a delayed long lasting effect in nervous
system activity and cognitive ability (Kaufer, 1998:373). This delayed nervous system
effect could possibly explain the delayed onset of PTSD and the delayed symptoms seen
in Gulf War veterans. The combination of wartime Stressors and exposure to PB could
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compound the effects seen in Kaufer' s study. Obviously, further studies are required to
look at the effects of combined stressful situations and PB intake.
Blood Brain Barrier
Several studies reviewed in this literature review have discussed the possible
repercussions from the increased permeability of the blood-brain barrier (BBB). The
need for homeostasis is very important in maintaining functions in the brain. Paul
Ehrlich, a bacteriologist, was the first to introduce the BBB. He found after injecting dye
into the blood stream that most organs would stain, yet the brain always remained
unstained. Ehrlich concluded that some sort of barrier to the brain prevented the flow of
toxins and other substances that could affect the central nervous system (Hanin,
1996:1307). Unlike the porous capillary walls found throughout the body, the BBB
consists of tight junctions between endothelial cells that make up the capillaries. This
creates a very selective system, where only particular substances can cross through the
endothelial cells. There are approximately 400 miles of these brain capillaries in a
human (Introduction to the Blood-Brain Barrier, 1999).
The cell or plasma membranes of the endothelial cells are composed primarily of
phospholipid and protein molecules. A double layer of phospholipids, which consist of
polar and nonpolar heads, in the cell membrane result in the restriction of water and
water-soluble molecules and ions through the membranes. Lipid-soluble molecules, on
the other hand, pass through the membrane rather easily (Fox, 1996:48-49). This is also
the case with the BBB where some chemicals can easily pass through, while others can
not. It has been found that lipid-soluble molecules with a molecular mass under 400-600
Dalton are transported readily across the BBB (Pardridge, 1998:1782).
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The high specificity of the BBB has caused several challenges in the medical field
when patients with brain diseases, such as those with Parkinson's disease, are treated
with drugs. Parkinson's disease can be treated with a chemical called dopamine, but it is
not able to enter the brain. A drug called L-dopa is used instead. L-dopa is actively
transported across the BBB and then converted to dopamine (Hanin, 1996:1307).
Problems are also seen with specific antibiotics. Penicillin cannot cross the BBB, so
when treating infections such as meningitis other antibiotics must be used (Fox, 1996:
151).
The tight junctions of the endothelial cells eliminate all transcellular bulk flow
across the BBB (Introduction to the Blood-Brain Barrier, 1999). Under these conditions,
a compound may gain access to the brain tissue via two pathways: lipid mediation
(passive diffusion) or catalyzed transport (mediated/active transport) (Introduction to the
Blood-Brain Barrier, 1999, and Fox, 1996). Astrocytes have also been found to interact
with the BBB. The BBB is surrounded by the extensions of these neurological cells
(Fox, 1996: 150-151). Thus, the brain is very protected against any chemical imbalance.
A more detailed understanding of the transport mechanisms across the BBB can
be gained by understanding the structure of the endothelial cells that make up the BBB.
Two membranes make up the endothelial cells. These membranes are separated by
approximately 300 nm of endothelial cytoplasm, and are termed the lumenal and
ablumenal membranes. The lumenal side faces the capillary or blood, while the
ablumenal side faces out toward the brain tissue. Therefore, transport must exist across
both lumenal and ablumenal membranes if a compound is to pass from the blood to the
brain (Introduction to the Blood-Brain Barrier, 1999). The bi-directional flow of both
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passive diffusion and mediated transport is also an important concept to be considered
when studying the BBB (Smith and Stoll, 1998:189).
Figure 2 is a simplified pictorial representation of the BBB. As noted in Figure 2
another form of transport across the BBB is related to enzyme activity or metabolism
where a chemical that initially may not be able to cross the BBB can be enzymatically
altered to a form that is allowed to cross the BBB (Brightman, 1989:75). This
metabolism of compounds acts as a detoxification system for the brain, but as discussed
above in multiple-chemical and stress research, competition or saturation of enzymes
may occur. Does this allow an increased amount of chemical into the brain tissue?
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(Abluminal Membrane)
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Figure 2. Transport Mechanisms across Blood-Brain Barrier
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In a study performed by Belova and others the capacity of the BBB was
investigated in the rat brain during normal conditions and stressful conditions. Acute
immobilization (IMO) was used as the stress exposure. They found that the brain became
more permeable after exposure to stress. With the use of dye they also found an
increased level of dye penetration in the brain following the stress. Dye was found in
specific brain regions involved in autonomic regulation. The autonomic nervous system
controls the involuntary responses in the body, such as increased heart rate or increased
blood glucose (Fox, 1996:216). The penetration of dye into the brain could explain the
adverse effects or symptoms seen during stressful conditions (Belova and others,
1982:116).
In 1991 Sharma and others supported the conclusions reached in the above study.
During a rat exposure to forced swimming, researchers found an increased BBB
permeability in specific regions of the brain. Decreased metabolism, altered blood flow,
and interactions with serotonin, a neurochemical compound, were cited as possible
explanations behind the BBB permeability (Sharma and others, 1991:212,218). A
decrease in BBB metabolism explains why an increase in dye was transported to the
brain. The increased permeability in the BBB was only found during 30 minutes to 120
minutes after the forced swim exposure, and increased permeability was limited in
younger rats; thus the BBB permeability appears to be time and age dependent and is
thought to be reversible (Sharma and others, 1991:218).
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Chemical Exposure and Distribution
The purpose of this portion of the literature review is to gain an understanding of
the processes of chemical exposure and distribution in the human body. The study of
environmental toxicology includes the hazardous effects that a foreign substance can
have on human health. Physiologically-based pharmacokinetic (PBPK) modeling is one
method that can be used in the study of toxicology or toxicokinetics. Toxicokinetics is
concerned with the exposure, absorption, distribution, storage, biotransformation, and
elimination of toxicants in an organism (Hughes, 1996:21). An understanding of these
time-dependent processes is important when looking at the end effect a toxicant has on
the organism's system. The organism's specific response is also important. Each species
or individual will be affected differently. These effects can range from lethal to systemic,
acute to chronic, or immediate to delayed.
Absorption is the process by which a toxic substance crosses an epithelial cell
barrier in an organism. The three primary routes of absorption include absorption
through the skin, respiratory system, and digestive system. Knowledge of each of these
routes is vital in understanding the possible effects from a particular exposure.
Distribution through an organism's system occurs through the lymph or
bloodstream. Duration of exposure, dose, and chemical characteristics must all be
considered when determining the distribution of a toxicant to particular tissues in the
body. Other factors that are also important would include the concentration gradient
(concentration of the toxicant in the blood and tissues), volume of blood flow, volume of
target tissue, cardiac output ratios to each tissue, and a toxicant's affinity for a particular
tissue (Hughes, 1996:49-64).
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Once a toxin is distributed through the body, other processes, such as storage,
biotransformation, and elimination, occur. Storage occurs when a toxic substance
accumulates in a specific tissue. Storage occurs most commonly in the bone, kidneys,
liver, and fat (Hughes, 1996:67). Biotransformation is the process by which a toxic
substance is changed to alternative forms making elimination from the body easier. And
finally, elimination from the body occurs through several routes to include the following:
urine, feces, sweat, saliva, exhaled air, and milk.

Modeling
There is a need to establish a basic pharmacokinetic study on stressful situations
and the intake of chemicals. Estimates of health hazards during times of stress will be
very important in future incidents of wartime deployment, as well as in developing the
field of deployment toxicology. Pharmacokinetic modeling looks at the processes of
absorption, distribution, metabolism, and elimination by the body. Physiologically-based
pharmacokinetic (PBPK) modeling is a more recent technique that can be used to predict
chemical concentrations in specific tissue compartments. PBPK modeling is a more
accurate tool for exposure assessments since it uses the physiological mechanisms of the
human body, to visualize, validate, and predict the susceptibility of the human body to
chemical exposures (Brown, 1994:Ch.2,10).
Adequate epidemiological studies are hard to find, so human exposure studies are
usually based on animal studies. Animal studies require a tremendous amount of time
and resources, and also pose difficulties when extrapolating to human exposures. PBPK
modeling is one way to reduce the reliance on animal studies and provide more accurate
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predictions. The combinations of time-dependent uptake, distribution, metabolism, and
elimination of a chemical are used in PBPK modeling (Clewell, 1988:A125). Hazard
assessments become less complicated, and the extrapolation from animal to human
exposure becomes more accurate (Clewell, 1988:A125).
PBPK models compartmentalize various tissue groups into a system on the basis
of physical and biochemical parameters. Mass-balance differential equations are used to
represent the behavior of a substance within the system (Brown, 1994:Ch.2, 11). The
first widely recognized PBPK model was completed by Ramsey and Andersen in 1983.
They simulated the behavior of inhaled styrene in rats and humans (Ramsey and
Andersen, 1984:159). Their model organized tissue into the following four groups: 1)
highly perfused tissues, 2) moderately perfused tissues, 3) slowly perfused tissues, and 4)
tissues that metabolize a large amount of styrene (liver). The model was first simulated
to represent rats and then scaled up to represent human exposures. The rat model was
found to be very accurate when compared to actual rat exposure data used in
experiments. This provided a rational basis for the use of PBPK modeling in the
extrapolation of animal data to chemical hazards in humans (Ramsey and Andersen,
1984:172).
The Ramsey and Andersen model has become the foundation of PBPK research
(Brown, 1994:Ch.2, 13). Figure 3 is an example of a generic PBPK model. The alveolar
space and lung blood compartments represent the initial intake of a lipophilic chemical
through inhalation. The fat tissue compartment is very important due to a chemical's
affinity for fat. The muscle tissue compartment falls under the slowly perfused, and
represents lean tissues. The richly perfused tissue group would include those organs
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where blood flow is rapid, such as the heart, kidney, and brain. And finally, the liver
compartment represents significant metabolic activity. Each of these compartments is
linked through arterial and venous blood flow (Q variables) and specific chemical
concentrations (Cv and Cart variables) to each compartment.
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Figure 3. Physiologically Based Pharmacokinetic Model

Using numerical integration of a system of differential mass balance equations,
the rate of input, output, and metabolic activity through each compartment in the model
can be simulated (Brown, 1994:Ch.2,11). This basic model can be changed to include
more tissue compartments to address a specific chemical exposure, as well as account for
the interactions of stress on the human body.
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From the research that has been performed on the effects of stress on chemical
exposure it has been found that the brain and the BBB may play a very important part in
the chemical kinetics. Adding a single brain compartment to the model developed by
Ramsey and Andersen will not accurately reflect the mechanisms of transport across the
BBB from the blood into the brain tissue. Figure 4 contains the modified PBPK model
that will be used in this study. The brain was divided into three sub-compartments (1brain blood, 2-blood-brain barrier, and 3-brain tissue) to show a more accurate
representation of the transport and metabolism that occurs in the human brain.
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Figure 4. PBPK Model with the Addition of the Three Brain Compartments
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A PBPK model like the one in Figure 4, which also addresses the interactions of
stress and chemical exposure, can now explore the system behavior and help predict the
causes behind the Gulf War Syndrome. Through the use of a developed model we can
learn what variables are important and investigate changes in these variables and the
effect they have on human health.
Model Parameters
The parameters necessary for the development of a PBPK model include
physiological values, partition coefficients for the specific compound in question and
metabolic values. Physiological values can be used with several different chemical
compounds. Values for several chemical compounds have been determined
experimentally for use in PBPK models. The compound-specific parameters in this
particular model have initially been defined to match the chemical characteristics of
trichloroethylene (TCE). Several PBPK models have been developed for TCE and
human exposure. TCE was chosen due to the abundance of information and research
performed on this chemical in PBPK models.
Several difficulties arise when considering the concept of stress. Little effort has
been devoted to developing a specific classification of stress or Stressors. There is also a
lack of consistency with the stress research protocols that have been used in past
experiments on rats and humans (McCarty, 1989:5). These issues should be considered
when defining the parameters for this PBPK model. Table 1 summarizes one
classification system that has been used to identify various Stressors.
An individual under a deployment situation may undergo several types of
Stressors that fall within each of the categories in Table 1. The model developed in this
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thesis will be a starting point for exploring the behavior and physiological changes that
occur under emotional and physical stress. Physical activity or exercise is one type of
Stressor that is well understood in its effects on the human body. The physiological
changes during exercise and the impact these changes have on chemical kinetics in the
body will be addressed in this model.
Table 1. Classification of Stressors (Elliott and Eisdorfer, 1982)
1. Acute, time-limited Stressor
2. Stressor sequence

e.g. brief exposure to a natural predator
e.g. changes set in motion by a single
precipitating event, such as a loss of a
family member or job
e.g. recurring Stressor such as preparing
monthly reports
e.g. a permanent or persistent physical or
emotional disability

3. Chronic, intermittent Stressor
4. Chronic Stressor

The study of exercise has been very important in the exploration of stress and how
stress effects the human body. Animal studies have used the forced swim stress protocol
and shaker stress test, while human studies have used the basic treadmill test. Physical
activity is just one of the many types of stress that initiates the stress response and
triggers changes in the cardiovascular system. Physical activity results in an increase in
ventilation, cardiac output, and distribution of cardiac output. The flow to skeletal
muscle or the slowly perfused tissue compartment will increase due to redistribution
away from the fat and liver compartments, while the richly perfused tissue compartments
will maintain the same amount of blood flow. This redistribution of blood flow is a very
important mechanism that enables the body to maintain homeostasis for vital organs such
as the brain and kidneys. Table 2 lists the physiological and biochemical parameters
found in the literature for both rest and physical activity. These values will be used to
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develop the initial PBPK model for stress and chemical exposure. It should be noted that
the biochemical parameters could be redefined for a different chemical at any point in the
modeling process.
Table 2. Physiological and Biochemical Parameters (TCE) for a Human Simulation
PARAMETER AT REST
BW
QP
QC

70
300
312

HEAVY PHYSICAL
ACTIVITY
70
2100
594

QF
QS
QR
QL

15.6b
78b
137.28"
81.12"

9.36°
124.8°
137.28c
40.56°

FF
FS
FR
FL

0.05b
0.25"
0.44"
0.26"

0.03°
0.4°
0.44°
0.13°

VF
VS
VR
VL

13.3
43.4
3.5
1.82

13.3
43.4
3.5
1.82

PBloodAir
PF
PS
PR
PL

9.2
73.3
2.3
6.8
6.8

9.2
73.3
2.3
6.8
6.8

LKm
LVmax

1.5
291.58

1.5
291.58

Body Weight (kg)a
Alveolar Ventilation (l/hr)a
Cardiac Output (l/hr)a
Blood Flow rates (1/hr)
Fat
Slowly Perfused
Richly Perfused
Liver
Fractional Distribution of Blood Flow (%)
Fat
Slowly Perfused
Richly Perfused
Liver
Tissue Group Volume (I)b
Fat
Slowly Perfused
Richly Perfused
Liver
Partition Coefficientsb
Blood/Air
Fat/Blood
Slowly Perfused/Blood
Richly Perfused/Blood
Liver/Blood
Metabolic Parameters5
Michaelis-Menten Constant (mg/1)
Max. Velocity of Metabolism (mg/hr -kg)

a. Physiological Parameter Values for PBPK Models (1994)
a. Allen and Fisher (1993)
b. Rowell (1986)
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With the addition of the three brain compartments to the PBPK model it is
necessary to research the physiological and biochemical parameters for the brain as well.
Unfortunately, the available research literature has not focused on the transport or
metabolic mechanisms for the brain. The dashed boxes in Table 3 below are the values
that are not known and have not been found in the literature. These unknown parameters
will either be defined numerically or graphically.
Table 3. Brain Physiological and Biochemical Parameters (TCE)
PARAMETER
Blood Flow rates (1/hr)
Brain
OB
Fractional Distribution of Blood Flow (%)
FB
Brain
Tissue Group Volume (1)
Brain Blood Compartment
VBB
VBBB
Blood Brain Barrier
VBT
Brain Tissue
Partition Coefficients
PBB
BrainBlood/Blood
PB
Brain Tissue/Blood
Metabolic Parameters
BKm
Michaelis-Menten Constant (mg/1)
Max. Velocity of Metabolism (mg/hr -kg)
BVMax
Transport Parameters
Passive Diffusions
Transfer Rate
TR
Mediated Transports
Maximum Transport
Max Transport
Maximum Transport2
Max Transport2
Transport Constant
Transport Constant
Transport Constant2
Transport Constant2
- Physiological Parameter Values for PBPK Models (1994)

AT
REST

HEAVY PHYSICAL
ACTIVITY

37.44

37.44

0.12

0.12

-

-

1.4

1.4

1
7

1
7

-

-

-

-

-

-

-

-

The maximum transport values, and the brain Vmax will be defined based on a graphic
relationship with exercise. The literature supports the theory that as exercise intensity
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increases the permeability of the brain increases, and this relationship will be explored
with these three parameters in the model.
Conclusions can be drawn about these parameters and any role they may play in
chemical exposure through simulation and testing of the PBPK model developed in this
study. The development and testing strategy of the model will be discussed in the
following chapter. The testing will help gain confidence in a range of values for the brain
compartments listed above in Table 3.
Scaling
The development of allometric relationships in a PBPK model can also be an
important step in the testing of the model. The use of mathematical equations allows the
modeler to scale the model parameters to a specific bodyweight. The recommended
reference human body weight of 70 kg for males and 58 kg for females can be used
initially in the model, but it is also nice to have simulated the model over a range of
bodyweights. This helps the modeler gain confidence in the behavior of chemical
concentrations in various tissue groups. The scaling factors for tissue group volumes,
ventilation, cardiac output, and liver metabolic parameters that will be used in this study
are listed below in Table 4 (Allen and Fisher, 1993:72). The brain tissue will be the only
scaled parameter in the brain compartment, since scaling factors for the brain blood and
blood-brain barrier were not available. The impact of exercise on the alveolar ventilation
and cardiac output must be accounted for in this study since the major component of
interest is in fact the effects of stress. A more thorough discussion on the scaling of the
ventilation and cardiac output parameters is below in the "exercise" sub-heading.
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Table 4. Scaling Parameters

b

Alveolar Ventilation (l/hr)

SCALING PARAMETER
QPc

VALUE
*See below

EQUATION
QPC*BWA.74

QCc

*See below

QCC*BWA.74

VFC
VRC
VLC
VBTC

0.19
0.62
0.05
0.026
0.02

VFC*BW
VSC*BW
(VRc*BW)-VBT
VLC*BW
VBTC*BW

LVmaXc

14.9

Lvmaxc*BWA.7

Cardiac Output (l/hr)b
Tissue Group Volume (1)
Fat"
Slowly Perfused"
Richly Perfused"
Liver"
Brain3

vsc

Liver Metabolic Parameters'5
Max. Velocity of Metabolism (mg/hr -kg)
a. Allen and Fisher (1993)

Exercise
The varying intensities of exercise are important to consider when modeling the
effect of exercise on chemical exposure. Exercise may vary from moderate work to
extremely strenuous work. In a report compiled by the International Life Sciences
Institute the values for ventilation and cardiac output based on their linear relationship
with exercise were discussed (Physiological Parameter Values for PBPK Models,
1994:44,79). These exercise values, based on a 100% scale, can be used to define the
scaling parameters needed for cardiac output and ventilation. The scaling equation that
was listed in Table 4 for both ventilation and cardiac output was used to calculate varying
scaling factors (QCc and QPc) based on the standard male bodyweight of 70 kg (Fisher
and Allen, 1993:75). For example, the cardiac output and ventilation rate of an
individual weighing 90 kg and exercising at a level of 55% can now be calculated using
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the scaling factors listed below in Table 5. This value and the determined bodyweight of
the individual can then be input into the scaling equations listed above in Table 4.

Table 5. Exercise Parameters
Percentage-based value (0-100% scale)
Level of Exercise8
0
Rest
15
Moderate Physical Activity
25
Heavy Physical Activity
55
Strenuous Physical Activity
100
Maximal Physical Activity
a. Physiological Parameter Values for PBPK Models (1994)
b. Allen and Fisher (1993)

QCc
15"
25.61
38.81
54.33
77.62

QPc
12.9"
64.68
90.56
168.18
232.86

Analysis and Summary
Military personnel were exposed to varied risk factors. The studies performed on
chemicals and chemical interactions and the years of stress research support the serious
nature of the Gulf War Syndrome.
A large majority of the research hypothesizes that stress and increased
permeability of the blood-brain barrier have a large contributing role in the Gulf War
Syndrome. This may increase the effects of exposures to DEET, permethrin,
pyridostigmine bromide, and organophosphates. Several theories have been discussed in
this chapter, but the following three main issues will be the focus of the modeler as the
PBPK model is developed:
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1) Exposure to multiple chemicals as well as stress has an inhibiting effect on the
enzymatic system in the brain. Altered metabolism may allow more chemicals to
cross the blood-brain barrier (McCain and others, 1997, and Abou-Donia and others,
1996).
2) Stress increases permeability in the blood-brain barrier (Friedman and others, 1996,
Belova and Jonsson, 1982, and Sharma and others, 1991). The increased
permeability may be due to changes in the two types of transport across the bloodbrain barrier (passive diffusion or mediated transport).
3) Stress also causes changes in cardiac output, alveolar ventilation, and fractional
distributions to the tissue groups.
Determining the long-term behavior and understanding the mechanisms of stress and
chemical exposure will help fill the major gaps that exist. These impacts can be assessed
with the use of a PBPK model. A detailed methodology is provided in the next section.
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III. Methodology

This section will define the concepts and elements of the system dynamics
approach that will be used to develop a PBPK model. The proper modeling approach
will first be explored. The four stages of a system dynamic model development will then
be addressed. These stages are conceptualization, formulation, testing, and
implementation (Randers, 1980:285). It must be remembered that the system dynamics
process is iterative in nature (Shelley, 1999).

Model Approach
There are several different modeling approaches used to explore various system
behaviors. Each of these modeling approaches is based on different paradigms on how to
define, develop and interpret a problem (Meadows, 1980:24). The selection of a
modeling approach will depend on the particular requirements of a model.
In this thesis a kinetic model will be developed to address the feasibility of generating
a hypothesis of physiological changes during chemical exposure and stressful conditions.
Since this modeling effort is one of the first attempts at modeling the combinations of
chemical exposure and stress, it will be important to keep the focus fairly simple. The
questions that need to be addressed would include the following: Does the addition of
stress increase the chemical exposure to tissue groups in the body? Does stress play a role
in the effects experienced after chemical exposures?
The dynamic nature of modeling chemical exposure in the human body with the
addition of a Stressor will be a mechanistic process. Through the literature review, it has
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been shown that a chain of events occur during a stressful condition. This includes the
specific mechanisms of the endocrine and nervous systems. An aggregate level of the
endocrine and nervous system interactions will be portrayed to find the representative
behavior during exposure to chemicals and stress.
Keeping the above requirements of this model in mind, the system dynamics
approach will help provide the most insight into this thesis effort. This is based on
several reasons. First, this model will provide a general understanding of a real-world
system based on the fact that the model addresses a relatively new question in regard to
human exposures. Every element and relationship in the model will be based on an
identifiable real-world counterpart, thus leading to a better understanding of the system
(Meadows, 1980:34). Second, the development of this PBPK model will be very process
oriented, instead of product oriented (Meadows, 1980:28). Insights into the system will
be gained through an iterative and modular development of the model. And third, the
dynamic behavior of the model will arise from a causal structure within the system
(Meadows, 1980:31). The internal structure of this PBPK model will be of value in
understanding the overall behavior of the system.

Conceptualization
Conceptualization is the first stage in the system dynamics modeling process.
This entails becoming familiar with the problem, defining the questions to be addressed,
developing a reference mode, and describing the basic mechanisms in a causal diagram
(Shelley, 1999). The questions that will be addressed have already been presented in the
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research objectives in Chapter I. The remaining parts of the conceptualization stage will
be discussed below.
Reference Mode
One of the initial steps in the modeling process is to conceptualize a mental view
of the system forces that drive chemical exposure in the body. This mental view aids in
the development of a reference mode. Through the literature review it was decided that
there would be five main tissue groups in this system: fat, slowly perfused, richly
perfused, liver, and brain. These key compartments or accumulation points in the model
are associated with the following parameters: air concentration, ventilation, cardiac
output, arterial concentrations, venous concentrations, partitioning coefficients,
metabolism, and finally the fractional distributions to each tissue group.
A plot, or reference mode, representing the time development of the behavior of
tissue concentrations is important in providing a focus for the development of the flow
diagram. Chemical concentration in tissue (with no stress input) over time will rapidly
increase and then level off as the concentrations reach a steady state. As displayed in
Figure 5, it is hypothesized that stress will cause a more drastic increase in chemical
concentrations in the different tissue groups.
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Stress increasing initial chemical
concentration in tissues

Tissue
Concentrations
Chemical concentration
in tissues - no stress effects

Exposure Time

Figure 5. Reference Mode

Influence Diagram
The structure of any system dynamics problem is the interwoven chain of cause
and effect loops necessary to explain the system behavior. It is very important to ensure
that the loops within this influence diagram give rise to the behavior in the reference
mode. The reference mode should always guide the problem or behavior development in
the system dynamics process. Additional terms in the influence diagram will only be
added to express the logic of the reference mode.
Figure 6 is a simple influence diagram representing the cause-andreffect
relationships between arterial and venous concentrations and the chemical concentration
in a tissue.
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Arterial
Concentration

R

Chemical
Cone, in
Tissue

Venous
Concentration

Figure 6. Simple Influence Diagram

Each arrow represents the cause and effect relationships between each affected
parameter. The plus and minus signs symbolize either a positive or negative influence.
These positive or negative influences define whether the given feedback loops are either
reinforcing or compensating. A reinforcing loop (R), as seen in Figure 6, gives rise to an
expanding or unstable behavior. So, the chemical concentration in the tissue in Figure 6
will keep increasing. A compensating loop (C) gives rise to a dampened or stable or
goal-seeking behavior. The combinations of these loops can help explain the behavior
seen in Figure 5. A compensating loop must be present to account for the leveling off of
the tissue concentration to a steady state. It is also important to note that the closed loops
in an influence diagram are the key to establishing the system boundaries.
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Formulation
Formulation is the process of transforming the conceptual model to a real
operating system representation (Shelley, 1999). The influence diagram will be
mathematically coded into a modeling program, which uses numerical integration. The
system dynamics modeling software used for this research is STELLA Research 5.0, by
High Performance Systems. The flow diagram below in Figure 7 contains all
relationships represented in the influence diagram, Figure 6. This diagram adds to the
cause and effect loops by explicitly identifying accumulating stocks, flow rates,
concentrations, and other parameters identified in the initial steps of the modeling
process. The flow diagram should be consistent with the level of detail represented in the
influence diagram.

Chemical Cone in Tissue

Tissue Outflow

Arterial Concentration

—■

Venous Concentration

Figure 7. Simple Flow Diagram
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At this stage in the system dynamics process it may also be helpful to list the steps
that need to be taken from the initial flow diagram to the proposed final flow diagram.
The following sequence is an overview of the modular approach that will be conducted
towards completing this PBPK model.
1. Based on Ramsey and Andersen's PBPK model, a set of tissue groups will be
developed in the model. For this scenario it will be important to include a brain
compartment as discussed in Chapter 2. The model below in Figure 8 is the PBPK
model that will be used in this study. To realistically represent the transport and
metabolic mechanisms that occur, as shown in Figure 8, the brain tissue must be
divided into the three sub-compartments.

Qalv
Cinh

Qalv
Alveolar Space

Qtntal
Cven

Calv
Qtotal
Cart

Lung Blood

^

Fat Tissue

Cvf

Qf
Cart

Cvr

Richly Perfused

Qr
Cart

Cvs

Slowly Perfused

Os
Cart

Cvl

Liver

Ol
Cart
olisrr

L

Brain Blood

Qb
Cart

Cvb

\
Blood Brain Barrier

v

1

'
Brain Tissue

Figure 8. PBPK Model
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2. Due to the large amount of PBPK modeling that has been conducted on TCE
exposure, the model will be initially developed for solvent exposure under normal
(non-stressful) conditions. This exposure scenario is important because past
modeling literature is available that can be used for validation.
3. Clearly define flow parameters from the literature (i.e. - air concentration,
ventilation, cardiac output, arterial concentrations, venous concentrations, partitioning
coefficients, metabolism, and fractional distributions)
4. Comparing the behavior to actual exposure data will validate the model under normal
conditions.
5. Once the model has been validated different parameters will be used to describe the
exercise scenario. Using different cases of a stressed individual will aid in
determining if stress does have a potential impact on the distribution of chemicals in
the body.
6. Portions of the stress response will be sequentially added to the model and simulated.
An initial example of this might be to address physical activity and how physical
activity affects the behavior of the system under chemical exposure. The data
presented in Chapter 2 will be used to simulate behavior.
7. The end result of this thesis effort will be a developed model that will be a theoretical
prediction of behavior after stress exposure. Due to the fact that the previous models
used to build up to this point have been validated there will be a higher level of
confidence in the resulting behavior.
8. The simulation of these model scenarios and the manipulation of the PBPK model
will aid in drawing conclusions between the effects of stress on chemical exposures,
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specifically how chemical concentrations change in the brain tissues. Conclusions
would also like to be drawn on the brain biochemical parameters.

Testing
The concept of model testing refers to the comparison of a system dynamics
model to empirical reality for the purpose of either corroborating or refuting the model
(Forrester and Senge, 1980:210). Model testing is conducted to determine if the model is
an accurate representation of the system under study. Validation is the process of
establishing confidence in the soundness and usefulness of the model.
Once the flow diagram is completed and the parameters are defined, the
simulations can be run. Use of second opinion to avoid personal bias and a step by step
check for expected behavior at each stage should be conducted during the simulation to
insure verification. The testing should include further exploration of the behavior under a
stress influence to watch the general trends in concentration levels in the tissues. Once an
understanding of the general behavior is explored the process of building confidence in
the model must be conducted. There are several tests that can be used to build
confidence in a system dynamics model. The following validation tests will be used on
this PBPK model: structure-verification test, behavior-reproduction test, parameterverification test, extreme-conditions test, and behavior-anomaly. The first three validation
tests check the model structure, while the latter two test the model behavior (Forrester
and Senge, 1980:209).
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Structure-Verification Test
Structure-verification compares the model structure directly with the structure of
the real system. The structure of the model can be verified with the use of available
literature, and it is important during this time to ensure that there are no contradictions
between the model built and the real system. The system is a simple representation of the
tissues in the human body, so this must be considered when comparing the structure to a
real world, but the overall structure of the model should represent what would be
expected in the real human body. Review of the model structure by experts and advisors
may also be appropriate.
Behavior-Reproduction Test
The behavior-reproduction test will be applied throughout the simulation process
in making sure that the behavior generated is arising as a consequence of the model
structure. This test is used to examine how well the generated behavior matches the
observed behavior of the real system (Forrester and Senge, 1980:218). For this model, it
will be important to compare the generated behaviors to the reference mode developed
during the conceptualization stage.
Parameter-Verification Test
Parameters in the model will be compared to the real-world system. The
parameters must correspond either conceptually or numerically to the parameters in the
real system. Conceptual verification means that the parameters match the elements of the
system structure, while numerical verification matches model parameters to the
appropriate real system parameters appropriately (Forrester and Senge, 1980:213). Due
to the limited amount of research that has been performed on stress and chemical
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exposure, it may be suitable to consult the available literature or experts for the
plausibility of the parameter value ranges.
Extreme-Conditions Test
Extreme-conditions testing procedures examine the maximum and minimum
conditions. The use of maximum and minimum conditions will be simulated for several
parameters while the output behavior is monitored. If model behavior is unreasonable
under extreme conditions, it indicates possible errors in the model logic and structure.
For the PBPK model developed in this study, the steady state values of chemical
concentrations in the tissues will be an important indicator for the extreme-conditions
test. These steady state values can be determined by multiplying the air concentration,
blood-air partition coefficient, and tissue-blood partition coefficients. Each simulation
should match up with these steady state values for each tissue concentration even when
the model is analyzed under conditions that may not be normally experienced. Testing
with extreme values of exercise, bodyweight, and other physiological or biochemical
parameters and confirmation of the steady state values will aid in building confidence
during the extreme-conditions test.
Behavior-Anomaly Test
Behavior anomaly can be used through the initial development of the simulations
in tracing anomalous behavior back to structural causes. These causes often reveal flaws
in the model structure or model parameters, or in the case of this initial model an
anomalous behavior may suggest a real system behavior that has not been observed yet.
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Implementation
Implementation is the process of translating the information that was gained
through this system dynamics process to a concept that is easily understood and useable
by others (Randers, 1980:121). This basic PBPK may be an on-going tool to study the
behavior of chemical exposure and stress during deployment situations.
In summary, the methods discussed in this chapter provide an organized process
of building and testing a PBPK model that simulates stress and chemical exposure. It
must be remembered that the model developed is a simple, but accurate representation of
the human body and how the human body changes during stressful situations, such as in
exercise. Insights will be gained, which will help future model revisions to more
accurately depict the system behavior.
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IV. Results and Analysis

Following the methods presented in Chapter 3 the PBPK model was developed
and tested. This chapter presents the results and insights gained through the
conceptualization, formulation, and testing stages of the system dynamics approach. The
system dynamics modeling approach allowed the modeler to gain insights throughout the
three stages, not just the testing stage, and these insights into stress and chemical
exposure will be discussed in the sections below.

Conceptualization
As described in Chapter 3, the conceptualization stage allows the modeler to
become familiar with the problem, define questions to be asked, and develop a reference
mode and influence diagram. In the literature review for this thesis, information was
found on the mechanisms of stress and possible theories behind the Gulf War Syndrome.
The following reference mode and influence diagrams of the mechanisms and feedback
loops together form the dynamic hypothesis of this study.
Reference Mode
The information found was used to initially conceptualize how chemical
concentrations in the human body would behave during exposure to stress through the
use of a reference mode. It has been known and studied for quite some time how a
chemical concentration will behave in any particular tissue. Typically, the concentration
will rapidly increase and then level off as the concentration reaches steady state over
time. As already discussed and presented in Chapter 3 it is hypothesized that stress will
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cause the chemical concentrations in tissue to drastically increase and then eventually
level off at the same steady state value. It is important to remember at this point that the
addition of parameters that remove chemical concentrations from the body, such as
metabolism, will slightly alter the initial reference mode behavior. With the addition of
metabolism, chemical concentrations in a tissue during stress will not level off at the
same steady state value as the chemical concentration at rest, but the same basic behavior
will occur. Stress will cause a more drastic increase in chemical concentrations before
reaching a steady state. This steady state value can be calculated as the product of the air
concentration, the blood-air partition coefficient, and the tissue-blood partition
coefficient. Figure 9, the same reference mode as presented in Chapter 3 is the proposed
reference mode for the PBPK model developed in this thesis effort. This reference mode
represents the time development of the behavior of tissue concentrations and is important
in providing a focus for the development of the influence diagram and flow diagram.
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Stress increasing initial chemical
concentration in tissues

Tissue
Concentrations
Chemical concentration
in tissues - no stress effects

Exposure Time

Figure 9. Reference Mode

Influence Diagram
The behavior of the chemical concentration over time in the above reference
mode should be explained by an interwoven chain of cause and effect loops, or an
influence diagram, as explained in Chapter 3. The addition of stress to the influence
diagram should affect the initial uptake of chemical in the tissue groups. This structure is
used to explore the system behavior and refine the structure as appropriate.
The basic causal mechanisms and feedback loops of the five tissue compartments
with the addition of stress would make a very complex influence diagram. A portion of
the dynamic system, to include the fat and slowly perfused tissue compartments, are
displayed in the influence diagram below in Figure 10.
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Figure 10. Influence Diagram of Fat and Slowly Perfused Tissues

The example influence diagram shown in Figure 6 of Chapter 3 is a reinforcing
loop, where the chemical concentration will continue to increase in the tissue group. To
properly represent the behavior seen in the reference mode a few concepts were added to
the influence diagram in Figure 10. A goal-seeking behavior was added that acts upon
the reinforcing loop. This results in a compensating loop that keeps the concentrations in
the tissues under control. A good way to explain this is that a gap initially exists between
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the tissue chemical concentration and the steady state value. As the concentration
approaches the steady state, the gap value becomes smaller until steady state is attained.
At this point, if chemical exposure continues, the arterial inflow of the chemical to the
tissues will equal the venous outflow of the chemical. Exercise is also added to this
scenario, which will change the cardiac output, ventilation rate and fractional
distributions. These changes caused by exercise result in an increase in blood flow to the
tissue groups, which means an increase in chemical being carried to the tissues.
An influence diagram of the brain compartment can also be found below in Figure
11. The brain compartment was split into three different sub-compartments: the brain
blood, the blood-brain barrier, and the brain tissue. The same goal-seeking behavior that
was described above also acts upon the brain tissue to control the unstable loop formed
by the flow between the arterial concentration, brain blood compartment, and venous
concentration.
Based upon the literature review, three more exercise influences have been added
to the brain compartment. Exercise will decrease the brain metabolism at the blood-brain
barrier by increasing the production of binding compounds. This increase in binding
compounds results in a decrease in binding sites, which then results in a decreased brain
Vmax value and brain metabolism. The decrease in metabolism will result in an increase
of chemical past the blood-brain barrier. This behavior will continue, which results in a
reinforcing loop. Exercise will also influence the mediated transport processes on either
side of the blood-brain barrier. Exercise will decrease the maximum transport values.
This will result in a decrease in mediated transport, which will then allow more chemical
to pass through the blood-brain barrier. This is also an unstable or reinforcing behavior.
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Figure 11. Influence Diagram of the Brain Compartment

Formulation
The influence diagrams were used to input the behavior and mechanisms of the
system into the modeling program, STELLA. The resulting flow diagram should contain
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all relationships discussed in the influence diagrams. The flow diagram will also add to
the cause and effect relationships by explicitly identifying accumulating stocks, flow
rates, concentrations, and other physiological and biochemical parameters identified in
the initial steps of this modeling process. The flow diagram should be consistent with the
level of detail shown in the influence diagrams.
A modular approach was used in the formulation of the PBPK model. The steps,
as outlined in the methodology, built upon each other until the final product in STELLA
matched the PBPK model that was modified in the literature review to include the three
sub-compartments in the brain. The same figure is repeated here in Figure 12 for
convenience to the reader.
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The initial step taken in the formulation stage was to duplicate past work on
PBPK modeling and exposure to trichloroethylene (TCE). Allen and Fisher developed a
model for the solvent exposure under non-stressful conditions in 1993. The model
contained the four tissue groups, as developed by Ramsey and Andersen, and explored
the tissue concentrations of TCE and its metabolite, trichloroacetic acid (TCA) (Allen
and Fisher, 1993:72). The duplication was performed in the STELLA modeling software
and confidence was gained in the basic structure of the model developed. The model was
simulated with the same conditions that Allen and Fisher used in their model. An air
concentration of 140 ppm of TCE for an exposure time of 4 hours was used. Figure 13
contains the resulting behavior for the venous blood concentration. Confidence was
gained when the behavior in Figure 13 was compared to the venous blood concentrations
presented by Allen and Fisher's model (1193:78). Data from the Allen and Fisher's
model is overlaid on the simulation performed and marked as "+" in Figure 13.
The four tissue concentrations were never presented in the work done by Allen
and Fisher, but an important objective with this particular thesis effort was to produce the
behaviors of the various tissue concentrations under exercise conditions. So, it was
important to establish the four tissue concentrations in this initial model before adding the
additional brain compartment and exercise. The confidence gained from duplicating the
venous blood concentrations allowed the modeler to feel comfortable with simulating the
four tissue groups under the same conditions that were used to produce the output
behavior in Figure 13. Figure 14 contains a graph of the behavior of chemical
concentrations for the fat, liver, richly perfused, and slowly perfused tissue groups.
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1: Venous Blood Cone
2.20

1.10-

0.00

75.00

Figure 13. Venous Concentration after a 4 hr. exposure to 140 ppm of TCE

0.00
0.00

75.00

Figure 14. Tissue Group Concentrations after a 4 hr. exposure to 140 ppm of TCE
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The second step taken was to modify the model with the addition of exercise. The
exercise impacted the alveolar ventilation rates, cardiac output, and fractional
distributions to the four tissue groups. The model was then run to insure a reasonable
response in the expected behavior when stress was added to a chemical exposure
scenario. The resulting output of chemical concentrations under resting conditions and
exercise conditions was similar to the behavior predicted in the reference mode, Figure 9,
lending credence to the model algorithm as a reasonable representation of the
physiological system. Below, Figure 15 is the result of the fat concentration simulated at
rest (line #1) and then simulated under exercise conditions (line #2).

1: Fat Cone at rest
600.001

2: Fat Cone under exercise

300.00-

0.00

1000.00

Figure 15. Fat Concentration in Initial PBPK model (1 - Rest, 2 - Exercise)

The next step taken was to add the brain tissue compartment and finally represent
the model structure developed in Chapter 3. To accurately represent the transport
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mechanisms across the lumen and ablumen membranes of the blood-brain barrier and the
metabolic activity that takes place, the brain compartment was divided into three
accumulating compartments. Difficulties with the software program arose at this point.
The volume of the brain blood sub-compartment had such a small value that numerical
integration problems developed. This resulted in nothing being transported to the brain
tissue compartment. It was important to get around this software limitation and see the
overall behavior of the chemical in the brain compartments. The volume of the brain
blood sub-compartment was increased to a large enough value that behaviors produced
could be studied. This unrealistically large volume'for the brain blood sub-compartment
is still relatively small compared to other tissues, and the inaccurate accumulation of
chemical in the blood is not considered significant in characterizing system behavior.
Several assumptions were also made with the addition of the brain subcompartments. As discussed in the literature review, minimal information and data was
found on the biochemical and physiological parameters of the brain. These parameters
were assigned realistic, but arbitrary values to enable simulation. It is hoped that
conclusions can be drawn that will help narrow the range of the values assigned. Another
large assumption pertained to the brain blood sub-compartment. It was assumed that this
was a homogeneous and well-mixed compartment that represented the average of the
arterial and venous concentrations over time. The blood-brain barrier was also assumed
to be in the aqueous phase as intracellular fluid. This allowed the partition coefficient
between the brain blood and blood-brain barrier sub-compartments to be defined as 1, an
exchange between two similar phases.
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The final steps in the formulation stage included the addition of exercise
influences on the metabolism and transport processes in the brain and the addition of the
scaling parameters so that the PBPK model could be simulated for any bodyweight.
Based on the information in the literature review a linear relationship was established
between exercise and the brain metabolism, passive diffusions, and mediated transports.
As exercise increased each of these values would decrease in value. These relationships
are supported by the several studies discussed in Chapter 2, which point to an increase in
permeability or a decrease in metabolism during exercise (McCain, 1997; Abou-Donia,
1996; Friedman, 1996; Belova and Jonsson, 1982; and Sharma, 1991). The information
found during the literature review was also used to scale the alveolar ventilation and
cardiac outputs to a specific and exercise level. The tissue volumes and liver metabolic
activity was also scaled to bodyweight. The final flow diagram developed in STELLA
can be referenced in Appendix A. The equations and documentation for this flow
diagram can be referenced in Appendix B.
The modular approach used in this formulation stage allowed the modeler to gain
confidence in the modeling process. The focus of this formulation was to represent the
behavior presented in the reference mode and described through the influence diagrams.
Portions of the stress or exercise response were sequentially added to the model, which
also helped the modeler gain confidence as well as understand the specific mechanisms
behind the influence of exercise on chemical concentrations in the five tissue groups. It
was also important to keep the research goals, which were identified in the introduction
of this thesis, in mind as the formulation stage was taking place.
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Testing
After the development of the PBPK model, numerous simulations were conducted
in order to gain an understanding of the behavior of chemical concentrations during
exercise conditions. Several issues were kept in mind during the testing stage. First, the
levels of exercise and the impact this had on the behavior of chemical concentration in
the body were very important. Second, testing different bodyweights was important to
ensure the model was performing as intended for any particular individual. And finally,
the metabolic activity in the blood-brain barrier and the transport parameters were of high
interest due to the possible impacts of increased exposure to the central nervous system,
as well as the fact that this area of research is just beginning. Focusing on these issues
and the five validation tests outlined in Chapter 3 will help increase the confidence in the
resulting behaviors of the PBPK model.
The initial verification of the model compared the chemical concentrations in the
seven compartments for resting conditions and heavy exercise conditions (25%). The
exposure scenario for this test was an exposure of 140 ppm of TCE for 4 hours. This
exposure scenario will be used for the remainder of the testing phase of this thesis.
However, instead of the concentrations leveling off at a steady state they should drop ^
back down after the 4 hours of exposure. Figure 16 represents the fat tissue
compartment. The 1st line is the fat concentration of TCE at rest and the 2nd line is the fat
concentration at heavy exercise.
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1: Fat Cone at rest

2: Fat Cone under heavy exercise

40.00 -v

20.00 ■

50.00

Figure 16. Fat Concentration (1-Rest, 2-Heavy Exercise)

Figure 16 does reflect the reference mode that was predicted in Figure 9. The
time was extended to 50 hours to see the general behavior over time. The concentrations
will eventually reach a steady state level of tissue concentrations, or as is the case above
go back down to zero concentration. A definite difference between rest and heavy
exercise conditions are noted during this simulation. Appendix C contains the remaining
six compartments (Figures 35-40) for the same scenario as described above with the fat
tissue. The remaining six compartments include: liver tissue, richly perfused tissue,
slowly perfused tissue, blood-brain barrier, brain blood, and the brain tissue.
These simulation runs were the first steps taken in the initial verification process
to determine if the model is performing as expected. Once the simulations have been run
and an understanding of the general behavior is explored, the process of building
confidence in the model must be conducted. Validation is the actual process of
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determining whether the conceptual model is an accurate representation of the system
under study (Shelley, 1999). This is a very important step in establishing the usefulness
of the PBPK model. The results of the five validation tests will be analyzed in the
following order: structure-verification test, behavior-reproduction test, parameterverification test, extreme-conditions test, and behavior-anomaly test.
Structure-Verification Test
The structure of the PBPK model must accurately reflect the actual structure of
the human body, and contain enough detail to resemble the processes that play a part
during a chemical exposure in a real world scenario. Structure-verification can be
performed a number of ways: comparison with the reference mode and influence
diagrams, verification through the literature, and consultation with advisors. The model
structure seen in Appendix A was built based upon each of these methods.
The reference mode and influence diagrams were developed based on literature in
the study of chemical concentrations, as well as in the study of exercise and stress. The
model was then modularly built upon this literature and the structure of the real system.
For the brain compartment, there was not a lot of information available that could be used
to characterize several of the parameters in this system dynamics model. The most
logical hypotheses were drawn from this information to develop the brain compartment.
The model was reviewed and confirmed by advisors at several points during the
development of the model. Because the initial output of the model matches the reference
mode, the model structure is assumed to be valid for representation of general system
behavior at the chosen level of detail.
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Behavior-Reproduction Test
This test examines how well the model matches the real system behavior over
time. The first round of testing focused on the changes in chemical concentrations in
each of the tissues during changing levels of exercise. Each of the seven compartments
was simulated for each exercise value assigned in Chapter 2. The compartments were
first simulated during resting conditions, and then each additional exercise level was
added to the same graph so that observations and comparisons regarding the resulting
behaviors would be easier to make. The simulations were first run for 30 hrs at the 140
ppm exposure of TCE for 4 hours. The simulation duration was then decreased to 15
hours so that the behavior of the tissue concentrations would be easier to observe. Figure
17 shows the results of the fat tissue concentrations for this simulation. Again, line #1
corresponds to 0% exercise, line #2 to 15% exercise, line #3 to 25% exercise, line #4 to
55% exercise and finally line #5 corresponds to 100% exercise. The concentrations in
Figure 17 follow the behavior that was predicted in the reference mode. As the exercise
intensity increases the concentrations in the tissues will initially increase at a faster rate,
and the concentrations will peak at higher levels. The results for the remaining six
compartments for this same simulation can be found in Appendix C (Figure 41-46). Each
compartment had the same basic behavior as above in the fat tissue.
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1: Fat Cone-rest

2: Fat Conc-15%

3: Fat Conc-25%

4: Fat Conc-55%

5: Fat Conc-100%
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Figure 17. Comparative Graph of the Fat Concentrations for Five Exercise Levels

The second round of behavior-reproduction testing focused on the changes in
chemical concentrations in each of the tissues during changing levels of bodyweights.
During this portion of the testing an anomalous behavior was found, which will be
discussed in the "behavior-anomaly test" section below.
Bodyweight was an important parameter to test to ensure that the tissue
concentrations of a 60 kg individual during exercise were not only behaving similar to the
reference mode and at slightly greater concentrations when compared to a 110 kg
individual. A sensitivity analysis was simulated for each of the tissue compartments
with the bodyweight starting at 60 kg and ending at a maximum of 110 kg. The results of
the fat tissue concentrations are below in Figure 18 and, as expected, the tissue
concentrations will decrease as the bodyweight increases. This relationship remains valid
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in the remaining compartments as well, which can be found in Appendix C (Figures 4752).

1:FatConc-60kg

2: Fat Conc-72.5 kg 3: Fat Conc-85 kg

4: FatConc-97.5 kg

5: FatConc-110 kg

80.00-1

40.00-

0.00
30.00

Figure 18. Fat Tissue Concentrations for Increasing Levels of Bodyweight.

At this point in the testing, confidence has been gained in the behaviors of the fat,
liver, richly perfused, and slowly perfused tissue groups. The resulting behavior of each
of these tissue groups with the addition of exercise and the model structure for these
tissue groups is assumed to be correct. The remaining tests will focus on the three brain
sub-compartments. There are still a lot of questions that need to be answered as to how
the transport processes and the metabolic activity in the brain affect the brain tissue
concentrations during exercise.
Parameter-Verification Test
Comparing the model parameters to knowledge of the real system is another test
that aids in describing the real world system of interest. The parameters should
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correspond conceptually and numerically to the real system (Forrester and Senge,
1980:212). This test was very important in the validation of this PBPK model.
Minimum research has focused on stress and chemical exposure, specifically pertaining
to the brain tissue. As discussed in Chapter 2, several of the brain parameters were not
found in the literature, so determining a plausible range of values for the physiological
and biochemical brain parameters will aid in gaining confidence in the model. This
parameter-verification testing phase was also used as a behavior-sensitivity test. As each
of the parameters was tested, the sensitivity of the model behavior to the changes in
parameter values was also observed.
Before the following testing is discussed, it is appropriate at this point to review
the roles and relationships of a few of the brain parameters and transport processes.
There are two sets of transport processes in the brain compartment. There is both a
mediated transport and a passive diffusion between the brain blood and blood-brain
barrier, as well as another mediated transport and passive diffusion between the bloodbrain barrier and brain tissue. Refer to Appendix A to see these transport processes in the
brain compartment. These processes are duplicates of each other. And, since one of the
objectives of this thesis effort is to understand the behaviors and interactions of the brain
parameters, it is reasonable to focus on one set of transport processes (mediated transport
and passive diffusion between the brain blood and blood-brain barrier sub-compartments)
during the parameter testing.
The transfer rate defines the rate at which the flow of chemical is transferred
between the brain blood and blood-brain barrier by passive diffusion. The transport
constant and maximum transport values define the process of mediated transport between
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the two compartments. These values are not metabolic parameters, but parameters that
act upon the permeability across the blood-brain barrier. The mediated transport can
change the permeability in either direction. This process can be described by an analogy
of a gate that either closes or opens wider to allow more chemical in. Finally, the brain
Km and Vmax parameters define the saturable metabolism process from the blood-brain
barrier. Km is defined as the metabolic half-saturation rate or substrate affinity for a
chemical within the blood-brain barrier endothelial cells (Allen and Fisher, 1993:73).
Vmax defines the maximum rate of enzymatic metabolism that can occur from the bloodbrain barrier.
The first round of parameters that were tested included the following: brain/blood
partition coefficient, transfer rate, transport constant, and the brain Km parameter. Each
of these parameters affected the overall behavior of the brain concentrations as expected.
As each of these four parameters were increased, an increase in the blood-brain barrier
and brain tissue concentrations occurred. There was no change or a very minimal change
in brain blood concentration. This makes sense because the brain blood compartment in
this model is functioning as a continuous transfer phase between the blood and bloodbrain barrier. An example of the results observed can be found below in Figures 19-21
for the transport constant (TC). The parameter was simulated through a sensitivity
analysis where the value was increased from .5 to 3 for the three brain sub-compartments.
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Figure 19. Sensitivity of the Transport Constant's Effects on Brain Blood
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Figure 20. Sensitivity of the Transport Constant's Effects on BBB
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2:TC = 1.13

4:TC = 2.38

3:TC = 1.75

5: TC = 3

11.25

15.00

Hours

Figure 21. Sensitivity of the Transport Constant's Effects on Brain Tissue

The transport constant also plays a role in the behavior of the mediated transport
process between the brain blood and blood-brain barrier sub-compartments. The effects
of varying transport constant on the mediated transport between the brain blood and
blood-brain barrier compartments can be seen in Figure 22. The behavior of the
mediated transport in Figure 22 was expected. As the transport constant was increased
the mediated transport would become more positive or less negative. This is due to the
bi-directional flow of mediated transport between the brain blood and blood-brain barrier
sub-compartments. A less negative mediated transport process correlates to a smaller
amount of chemical being transported back to the brain blood from the blood-brain
barrier; which results in a an increase in blood-barrier and brain tissue concentrations
(Refer back to Figures 20 and 21).

72

2:TC = 1.13

3:TC = 1.75

4: TC = 2.38

5: TC = 3
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Figure 22. Transport Constant's Effects on Mediated Transport

The results from the remaining simulations, to include the brain/blood partition
coefficient, the transfer rate, and the brain Km parameter can be found in Appendix C
(Figures 53-61) respectively. These simulations include the three brain sub-compartment
concentrations under varying brain/blood partition coefficients (2-20), varying transfer
rates (2-25), and varying brain Km values (5-3).
One interesting observation was made during the simulation of the above
parameters in the blood-brain barrier. As the parameters increased, an increase in the
blood-brain barrier concentration occurred. But, as the concentrations increased, it was
noted that there was also a more rapid decrease in concentration after the 4-hour
exposure. In Figure 23, this behavior can be seen in the blood-brain barrier concentration
during increasing transfer rate values. The fifth line corresponds to a transfer rate of 25,
and it does in fact decrease at a greater rate than the three previous transfer rates (values 7.75,13.5,19.3).
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Figure 23. Rapid Decrease in BBB Concentration as the Transfer Rate Decreases

A sensitivity analysis of varying the transfer rate and its affects on passive
diffusion was also simulated. The resulting behavior can be seen in Figure 62 in
Appendix C. As the transfer rate increases the passive diffusion between the brain blood
and blood-brain barrier increases in both directions.
The effects of increasing intensities of exercise on passive diffusion were also
explored. As expected the passive diffusion from the brain blood increased and the
amount of chemical transported through passive diffusion from the blood-brain barrier
back into the blood increased as well. Figure 24 contains this behavior from the
simulation. The behavior points to the theory that exercise causes the blood-brain barrier
to become more permeable; thus allowing more chemicals through to the brain tissue.
Note that during the first couple of hours of the 4-hour exposure the passive diffusion
increases, so more is transported to the blood-brain barrier. Around the 3.5 - 4 hour
point the passive diffusion process increases back towards the brain blood sub74

compartment. Since, exercise does not directly affect passive diffusion, this behavior
could be explained by that fact that there is an increase in the blood flow rate that will
affect the tissue concentrations, therefore affecting the rate of passive diffusion. Figure
63 in Appendix C contains the same simulation but for a bodyweight of 110 kg.

1: At Rest

2: 25% Exercise

3: 50% Exercise

4: 75% Exercise

5:100% Exercise

5.50-r-

2.00

15.00

Figure 24. Passive Diffusion Effects to Increasing Exercise Levels

The final round of parameter testing focused on the parameters that were defined
by a linear graphical relationship with exercise. The first parameter that was tested was
the brain Vmax value, which directly affects the metabolic rate within the blood-brain
barrier. This value defines the maximum rate of the saturable metabolic or enzymatic
activity. As discussed in the literature review the brain Vmax may have some influence
on the amount of chemical that is allowed into the brain during a stressful situation. A
graphic relationship was developed between the brain Vmax and exercise, where Vmax
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decreases in value as the intensity of exercise increases. The decrease in Vmax will then
decrease the overall metabolic rate. Figure 25, shows the sensitivity analysis that was run
for metabolism for a 70 kg individual. Exercise was increased from 0% through 100%.
The initial range that was defined for the brain Vmax was 19.5 down to 11.9.

1: At Rest
4.001

2: 25% Exercise

3: 50% Exercise

4: 75% Exercise

5:100% Exercise

2.00-

0.00
15.00

Figure 25. Metabolism Response to Increasing Exercise Levels

An interesting behavior appears above in Figure 25. The metabolism initially
increases between rest and 25% exercise, which was not anticipated. There are several
factors that could play into this behavior. It must be remembered that other transport
processes are occurring in the brain compartment, and one of these processes could be
more dominant during the initial exercise periods. The expected behavior is observed
when exercise increases to 50% or greater - the metabolism of the chemical decreases
which should result in an increase in the blood-brain barrier and brain tissue
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concentrations. Figures 26 and 27 show these two brain concentrations. The
concentrations increase as exercise increases and metabolism decreases, but the bloodbrain barrier increases in very small increments as exercise exceeds 50%.
1: At Rest

2: 25% Exercise

3: 50% Exercise

4: 75% Exercise

5:100% Exercise

4.00-Y

2.00-

0.00
Hours

Figure 26. BBB Concentration as Exercise Increases
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Figure 27. Brain Tissue Concentration as Exercise Increases
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Another interesting observation was found when the same simulation was run for
metabolism and increasing exercise, for a 110 kg individual. There is no difference
between the metabolism for the two bodyweights tested. This finding helps build
confidence in the model since there should not be a difference due to the way the model
was built. As discussed in Chapter 2, the blood-brain barrier was not scaled to varying
bodyweights. If the blood-brain barrier was scaled to bodyweight, then the behavior of
the metabolic activity would vary based on different sizes of individuals. Scaling
parameters were not found for the blood-brain barrier during the literature review, and
this is just one of the few areas that can be pursued in further research to make the brain
compartment more of a realistic representation of what actually occurs during chemical
exposure and stress. The results of the simulation for 110 kg can be found in Appendix C
as Figure 64.
After re-evaluating all the relationships that occur in the brain compartment
during exercise, it became clear that since metabolism is a saturable process the
concentrations in the blood-brain barrier will start to level off as the saturation point is
met. The brain, on the other hand, will still increase in concentration due to the increased
permeability of the blood-brain barrier. This behavior supports the predictions of several
articles reviewed during the literature review.
The next graphical relationship that was explored was the maximum transport
parameter, which affects the behavior of the mediated transport between the brain blood
and blood-brain barrier. The same simulation was conducted where the exercise intensity
was increased and as defined by the graphical relationship the maximum transport
parameter would decrease, which in turn had an impact on the mediated transport. As
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expected, the simulations initially resulted in an increased transport from the brain blood
to the blood-brain barrier. After the four-hour exposure was complete an increased
transportation from the blood-brain barrier to the brain blood occurred. This finding
again supports the findings of several studies that focused on stress effects in the brain.
This behavior of this mediated transport for a 70 kg individual can be seen below in
Figure 28. Figure 65 in Appendix C contains the same simulation but for a 110 kg
individual. Again the behavior for the heavier bodyweight is the same as the lighter.

2: 25% Exercise

1: At Rest

3: 60% Exercise

4: 75% Exercise
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Figure 28. Mediated Transport Response to Increasing Exercise Levels

Extreme-Conditions Test
This test was fairly straightforward for this model due to the numerical integration
difficulties found in the software program. If any values were either too small or too
large, the resulting behavior during the simulations was very anomalous. As already
discussed above an increase in exercise, which ranged from 0% to 100%, resulted in the
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normal behavior expected. The model was tested with increasing levels of bodyweight,
which resulted in a flat line behavior due to the small brain blood volume. The model
was also tested under decreasing bodyweight conditions and increased air concentrations
of TCE. The output behavior was normal in terms of what was expected for each of these
simulations. Figures 66 and 67 in Appendix C contain the simulation output for a
bodyweight of 40 kg and an air concentration of 300 ppm respectively.
Behavior-Anomaly Test
This test was used throughout the testing stage of the system dynamics process.
When a behavior from the model deviated from what was expected of the behavior in the
real system the anomaly was traced back to structural causes. This occurred at several
points during the modular development of the model, but was crucial at two points during
the process.
The first anomaly occurred when the brain was divided into the three subcompartments to accurately reflect the metabolic and transport activities. When this step
was taken the blood-brain barrier and brain tissue concentrations immediately flat lined at
a zero concentration. The model was analyzed until it was concluded that there was not a
problem with the model structure but with the limits of numerical integration within the
modeling software. The volume of the brain blood sub-compartment was so small that
blood flow through the capillaries cleared all mass from the sub-compartment before any
opportunity to cross the blood-brain barrier. This problem was solved by increasing the
brain blood volume until the chemical concentrations in the other brain subcompartments were behaving as expected.
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A similar behavior occurred again in the model when bodyweight was increased.
An anomalous behavior was identified in the blood-brain barrier and brain tissue
concentrations during a sensitivity analysis of the five exercise values. Figure 29 and 30
are examples of the anomalous behavior seen in these two sub-compartments. In Figure
29 the blood-brain barrier concentration increases as the exercise value is increased from
0% (line #1) to 15% (line #2), 25% (line #3), and 55% (line #4). This behavior is
expected but when the exercise is increased to 100% (line #5) the blood-brain barrier
decreases back below the output from 55% exercise. A similar behavior is seen in Figure
30 where the brain tissue concentrations increases as the exercise value increases, but at
100% the concentration increases at a slower rate then at 55%. This behavior can be seen
where line #5 crosses over line #4 just before the maximum concentration is reached.
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Figure 29. Anomalous Behavior in the Blood-Brain Barrier
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Figure 30. Anomalous Behavior in the Brain Tissue

The behavior for both these tissue concentrations was again tracked to the brain
blood volume, which had already been increased to 2.17 liters. The problem was traced
back to the numerical integration limitation with the STELLA software program. The
mass of contaminant in the brain blood compartment was too small for the time step
between calculations (DT), and this lead to an inaccurate simulation. The brain blood
volume was increased again until the expected behavior was seen. The final value for the
brain blood volume was 3.5 liters. This may be unrealistic in the real world, but the
overall behavior was important in this thesis effort and increasing the volume will not
impact the behavior. Figure 31 and Figure 32 show the blood-brain barrier and brain
tissue concentrations simulated with this new brain blood volume. Notice how the
anomalous behavior disappeared and the tissue concentrations increase, as they should
with each increase in the exercise level.
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Figure 31. Expected Behavior in the Blood-Brain Barrier
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Figure 32. Expected Behavior in the Brain Tissue
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The same simulation above was conducted again, but this time the brain blood
volume was increased by one order of magnitude to insure that the same behavior was
occurring in the blood-brain barrier and brain tissue compartments. The following
figures, Figure 33 and 34, are the results of this simulation. The expected behavior
occurred, which proves that the brain blood volume is not a sensitive parameter to the
output in this model. The compartment acts as a significant accumulator, but the same
behavior will occur with a wide range of values.

1: At Res!
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Figure 33. BBB output when Brain Blood Volume is Increased
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Figure 34. Brain Tissue output when Brain Blood Volume is Increased

The second anomaly occurred with the addition of the exercise influence in the
model structure. In the first stages of the model development, the exercise parameter's
affect on the maximum transport and brain Vmax parameters was defined incorrectly.
Exercise was also defined in a complicated manner, which only made the model
formulation more confusing. Initially, changes in exercise were defined by changes in
either alveolar ventilation or cardiac output and then this exercise level was directly
added on to the maximum transport gates and the Vmax in the brain. This definition was
reverse of what occurs in reality where changes in the alveolar ventilation and cardiac
output are a direct result of changes in physical activity. The simulation of the model
also resulted in a behavior that was not expected. The tissue concentrations would
increase and decrease in no particular order as the exercise level was increased. This
anomalous behavior was traced back to the how exercise affected the maximum transport
and Brain Vmax. A change to the structural development of exercise was done at this
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point, which made it easier to change the way exercise impacted the brain parameters.
Alveolar ventilation, cardiac output, the fractional distributions of blood flow, and the
brain metabolism and transportation processes were all changed to have a direct
relationship with exercise. If the exercise value changed in the model then these other
values would be effected. Changing the exercise parameter in the model made the model
structure more of an accurate representation of what happens in the real human body and
the resulting behavior was once again what was expected.
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V. Conclusions and Recommendations

The purpose of this research effort has been to build a model that predicts the
changes that will occur when stress is combined with chemical exposure. A
physiologically-based pharmacokinetic (PBPK) model is an excellent tool that can aid in
understanding the concepts behind stress and chemical exposure, as well as further the
research in understanding the etiology behind the Gulf War Syndrome.
A PBPK model has been constructed that provides the groundwork for studying
the internal interactions of the human body and how stress can change these interactions
to possibly increase the harmful effects of a chemical exposure. In this initial work the
model has investigated the effects of a Stressor, in this case exercise, on the system
behavior. Tremendous insights have been gained concerning this system through the
system dynamics modeling stages: conceptualization, formulation, and testing. This
chapter will complete the final stage of the system dynamic process, implementation, by
translating the insights and information gained with respect to the research objectives.
Strengths and weaknesses of the model and areas for further study are also addressed.

Research Objectives
Throughout the literature review and the modular building of the model,
knowledge was gained on the mechanisms of stress and chemical uptake and distribution
in the human body. Several studies have theorized that a large player in the human
body's response to stress is the brain. Homeostasis is crucial in the brain, and any
changes in the uptake or metabolism of chemicals could potentially disrupt this
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homeostasis and have many other harmful effects to the human body. A large amount of
literature was reviewed to learn about the brain and the blood-brain barrier.
This information was used to build a PBPK model that addresses a topic that few
if any PBPK models have done in the past. A quantitative description of the research was
input into STELLA using the system dynamics process. This process included the
conceptualization stage where a reference mode and influence diagrams were formed.
The testing phase was then conducted to simulate the model over a range of reasonable
parameter values. These simulations helped the modeler gain confidence in the model
and the resulting behaviors.
A hypothesis can now be formed as to the interactions of stress and chemical
exposure. It has been demonstrated through this thesis effort that exercise does have a
large influence on the chemical concentrations in the body; and, the brain is an important
component in these interactions. The blood-brain barrier is the gate to the brain tissue
and exercise can open this gate. It has been demonstrated that mediated transport,
passive diffusion, and metabolism in the brain are all contributing causes to an increase in
concentrations in the brain.
The question now is how can we prevent this possible harm to the brain? And,
how can we predict the consequences of stress on the human body? Hopefully, with
some future work on this model we may be able to use it as a tool to help predict and
explore these questions.
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Model Strengths and Limitations
Model Strengths
1. Provides insights and the groundwork for studying the effects of chemical exposure
and stress in combination.
2. Provides a simplified, but important basis for simulating the behavior of xenobiotic
chemicals in the brain tissue in the context of circulation throughout the physiological
system.
3. Suggests areas of future research that will be important in the implementation phase
of this model.
Model Limitations
1. Rests upon many generalities and assumptions of parameters in the brain
compartment portion of the model.
2. The stress response only addressed the physical aspect, not the emotional aspect.
3. The modeling software program had numerical integration limits, so the brain blood
volume was defined as an unrealistic value during the testing of the model.

Areas of Further Research
1. Expand upon the brain compartment portion of this model. The development of the
three sub-compartments is a realistic, but very simple description of the brain, blood,
and blood-brain barrier interactions. The transport systems may also be too simplistic
in this model. Bi-directional transport for both passive diffusion and mediated
transport was assumed. Uni-directional flows may be more appropriate in some
cases.

89

2. Explore behavior of other chemicals that may be more relevant to deployment
toxicology concerns. Eventually PB, DEET and all the other chemicals in question
could be used in the model to predict their effect in human tissue.
3. Using a more powerful version of STELLA or using a different software program for
the testing of this model would be helpful. The problems with the numerical
integration limits that were encountered during the testing of the model could be
avoided with a more powerful software program; and, more realistic values for the
parameters in the brain compartment could be used.
4. Add the mental or emotional aspects of stress to the model.

Conclusions
This model and the testing that has been performed have laid the groundwork for
further research, and will aid in the pursuit to understand and be able to predict and
control the effects of stress and chemical exposure during deployment scenarios, or in
any situation that may apply. The model developed appears to be a valuable tool for
gaining insights into the mechanisms behind stress and chemical exposure. It can also be
used to help define plausible parameters in the brain tissue. This information could assist
the military in understanding the etiology behind the Gulf War Syndrome, or at least help
fill major gaps that have hindered immediate identification of the disease.
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Appendix A - Model Flow Diagram
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Appendix B - Model Equations and Documentation
Blood Flow
Parameters
Air_Conc = Exposure*Chemical_MW/24450
DOCUMENT: This is the air concentration that an individual is exposed to. The
molecular weight of the chemical must be converted into parts per million (PPM).
Arterial_Blood_Conc =
(QP*Air_Conc+QC*Venous_Blood_Conc)/((QP/PBloodAir)+QC)
DOCUMENT: This represents the arterial blood flow, which connects each of the tissue
groups or compartments in this particular PBPK model.
Exercise = 100
DOCUMENT: Exercise values will be assigned a percentage value based on the level of
activity.
Rest = 0
Moderate Activity = 15%
Heavy Activity = 25%
Strenuous Activity = 55%
Maximum = 100%
QC = QCc*(BWA.74)
DOCUMENT: QC=Cardiac Output L/hr) that has been scaled down to a particular
bodyweight. 'Physiological Parameter Values for PBPK Models' (December 1994) - pg.
44. The following cardiac outputs are an example of the changing values for a 70 kg
male (QCc= 13.45).
Resting Individuals = 5.2 L/min = 312 L/hr
Moderate Exercise = 9.9 L/min = 594 L/hr
Heavy Exercise = 15 L/min = 900 L/hr
Strenuous Exercise = 21 L/min = 1260 L/hr
Maximum = 30 L/min = 1800 L/hr
QP = QPc*(BWA.74)
DOCUMENT: QP=Alveolar Ventilation (L/hr) that has been scaled down to a particular
bodyweight. 'Physiological Parameter Values for PBPK Models' (December 1994) - pg.
79 The following ventilation rates are an example of the changing values for a 70 kg
male (QPc = 12.9).
Resting Individuals = 5 L/min = 300 L/hr
Moderate Exercise = 25 L/min = 1500 L/hr
Heavy Exercise = 35 L/min = 2100 L/hr
Strenuous Exercise = 65 L/min = 3900 L/hr
Maximum = 90 L/min = 5400 L/hr
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VenousBlood Cone =
(FatVein_Outflow+LiverVein_Outflow+RichVein_Outflow+SlowVein_Outflow+Brain
Vein_Outflow)/(QC)
DOCUMENT: This represents the venous blood flow, which also connects each of the
tissue groups or compartments in this particular PBPK model.

Graphs
QCc = GRAPH(Exercise)
(0.00,13.4), (5.00,16.3), (10.0,20.6), (15.0,25.6), (20.0, 31.0), (25.0, 38.8), (30.0,42.3),
(35.0,45.4), (40.0,48.1), (45.0, 51.6), (50.0, 53.2), (55.0, 54.3), (60.0, 57.1), (65.0, 59.8),
(70.0, 63.6), (75.0, 67.5), (80.0, 70.6), (85.0, 71.8), (90.0, 73.0), (95.0, 74.9), (100, 77.6)
DOCUMENT: QCc = Cardiac Output Scaling Factor. A linear relationship between
exercise and the cardiac output scaling factors was formed based on the initial QCc (15)
value found in 'Pharmacokinetic Modeling of Trichloroethylene and Trichloroacetic Acid
in Humans' by Allen and Fisher (1993)'. A graph was important in forming this linear
relationship due to the fact that the scaling factor will change for different levels of
exercise, which will then effect cardiac output differently for different bodyweights. The
following are the scaling factors for each category of exercise.
When Exercise = 0 (Rest) QCc = 13.45
When Exercise = 15 (Moderate) QCc = 25.61
When Exercise = 25 (Heavy) QCc = 38.81
When Exercise = 55 (Strenuous) QCc = 54.33
When Exercise = 100 (Maximum) QCc = 77.62
QPc = GRAPH(Exercise)
(0.00,12.9), (5.00,24.5), (10.0,48.9), (15.0, 64.7), (20.0, 80.3), (25.0, 90.6), (30.0,104),
(35.0,113), (40.0,122), (45.0,141), (50.0, 156), (55.0,168), (60.0,175), (65.0,182),
(70.0,187), (75.0,194), (80.0,200), (85.0, 208), (90.0,217), (95.0,222), (100, 233)
DOCUMENT: QPc = Alveolar Ventilation Scaling Factor. A linear relationship
between exercise and the alveolar ventilation scaling factors was formed based on the
initial QPc (12.9) value found in 'Pharmacokinetic Modeling of Trichloroethylene and
Trichloroacetic Acid in Humans' by Allen and Fisher (1993)'. A graph was important in
forming this linear relationship due to the fact that the scaling factor will change for
different levels of exercise, which will then effect the ventilation rate differently for
different bodyweights. The following are the scaling factors for each category of
exercise.
When Exercise = 0 (Rest) QPc = 12.9
When Exercise = 15 (Moderate) QPc = 64.68
When Exercise = 25 (Heavy) QPc = 90.56
When Exercise = 55 (Strenuous) QPc =168.18
When Exercise = 100 (Maximum) QPc = 232.86
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Brain Compartment
Stock
Blood_Brain_Barrier(t) = Blood_Brain_Barrier(t - dt) + (Passive_Diffusion +
Mediated_Transport - Passive_Diffusion_2 - Mediated_Transport_2 - Metabolism) * dt
INIT BloodBrainBarrier = 0
DOCUMENT: This reservoir makes up the endothelial cells in the brain that make up
the barrier. This consists of the lumen side (facing the brain blood) and the ablumen side
(facing the actual brain tissue). This reservoir also represents the accumulation point in
the blood brain barrier where there is a biflow of material (passive diffusion and mediated
transport) passing between the blood brain barrier and brainblood.
Inflows
Passive_Diffusion - Gradient 1 *Transfer_Rate
Mediated_Transport = ((Max Transport*BrainBlood_Conc/PBB)/(Transport
Constant+BrainBlood_Conc/PBB))-((MaxTransport*BBB_Conc/PBB)/(Transport
Constant+BBB_Conc/PBB))
Outflows
Passive_Diffusion_2 = Gradient2*Transfer_Rate
Mediated_Transport_2 = ((Max Transport2*BBB_Conc/PB)/(Transport
Constant2+BBB_Conc/PB))-((MaxTransport2*Brain_Tissue_Conc/PB)/(Transport
Constant2+Brain_Tissue_Conc/PB))
Metabolism = (BVmax*BBB_Conc/PB)/(BKm+BBB_Conc/PB)
DOCUMENT: Metabolism was assumed to occur in the blood brain barrier for this
particular model. The saturable metabolic transformation of any particular chemical in
the blood brain barrier was defined using the Michaelis-Menten equation with the biochemical constants Vmax2 and Km2.
Stock
Brain_Blood(t) = Brain_Blood(t - dt) + (Brainjnflow - BrainVein_Outflow PassiveDiffusion - Mediated_Transport) * dt
INIT Brain_Blood = 0
DOCUMENT: Assumption - this brain blood reservoir is a homogenous well-mixed
compartment, representing the average concentration of the arterial and venous
concentrations. This reservoir represents the accumulation point in the brainblood where
arterial blood flow enters and venous blood flow exits.
Inflows
Brainjnflow = Arterial_Blood_Conc*QB
DOCUMENT: The fraction of the arterial blood flow that enters the brainblood portion
of the brain tissue compartment.
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Outflows
BrainVein_Outflow = QB*BrainBlood_Conc/PBB
DOCUMENT: This represents the fraction of venous blood flow that exits the
brainblood portion of the brain tissue compartment.
PassiveDiffusion = Gradientl*Transfer_Rate
Mediated_Transport = ((Max Transport* BrainBlood_Conc/PBB)/(Transport
Constant+BrainBlood_Conc/PBB))-((MaxTransport*BBB_Conc/PBB)/(Transport
Constant+BBB_Conc/PBB))
Stock
Brain_Tissue(t) = Brain_Tissue(t - dt) + (Passive_Diffusion_2 + Mediated_Transport_2)
*dt
INIT Brain_Tissue = 0
DOCUMENT: This reservoir represents the accumulation point in the brain tissue where
there is a biflow of material (passive diffusion and mediated transport) passing between
the brain tissue and the blood brain barrier.
Inflows
Passive_Diffusion_2 = Gradient2*Transfer_Rate
Mediated_Transport_2 = ((Max Transport2*BBB_Conc/PB)/(Transport
Constant2+BBB_Conc/PB))-((MaxTransport2*Brain_Tissue_Conc/PB)/(Transport
Constant2+Brain_Tissue_Conc/PB))
Parameters
BBB_Conc = Blood_Brain_Barrier/VBBB
DOCUMENT: This connector represents the concentration of chemical in the blood
brain barrier.
BKm=1.6
DOCUMENT: Km2 - Michaelis constant (mg/L). This parameter value is an assumption
at this time due to lack of data in the literature.
BrainBlood_Conc = Brain_Blood/VBB
DOCUMENT: This connector represents the concentration of chemical in the brain
blood.
Brain_Tissue_Conc = Brain_Tissue/VBT
DOCUMENT: This connector represents the concentration of chemical in the brain
tissue stock.
Gradientl = (BrainBlood_Conc-(BBB_Conc/PBB))
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Gradient2 = (BBB_Conc-(Brain_Tissue_Conc/PB))
Transport Constant = .8: This parameter value is an assumption at this time due to lack of
data in the literature.
Transport Constant2 = 1.75: This parameter value is an assumption at this time due to
lack of data in the literature.
Transfer_Rate = 2: This parameter value is an assumption at this time due to lack of data
in the literature.
VBB = 3.5: This value is larger than the real-world volume of the brain blood
compartment due to integration limitations with the software.
VBBB = .5: This parameter value is an assumption at this time due to lack of data in the
literature.
VBT = .02*BW
DOCUMENT: The brain tissue volume is scaled so that any bodyweight can be used to
find the behavior of chemical concentrations in a particular sized individual. The value
of .02 was found in - 'Physiological Parameter Values for PBPK Models' (A report
prepared by the International Life Sciences Institute Risk Science Institute. December
1994-Pg. 25).
Graphs
BVmax = GRAPH(Exercise)
(0.00,19.5), (10.0,18.8), (20.0,18.1), (30.0,17.3), (40.0, 16.4), (50.0,16.0), (60.0, 15.2),
(70.0, 14.5), (80.0,13.9), (90.0,13.2), (100, 11.9)
DOCUMENT: Vmax2 (mg/hr) - maximum rate of enzymatic (saturable) metabolism
Max Transport = GRAPH(Exercise)
(0.00, 15.0), (10.0, 14.4), (20.0, 13.8), (30.0, 13.3), (40.0, 12.8), (50.0, 12.3), (60.0, 11.7),
(70.0, 11.5), (80.0, 11.0), (90.0, 10.5), (100, 9.97)
Max Transport2 = GRAPH(Exercise)
(0.00, 29.8), (10.0, 28.5), (20.0, 27.0), (30.0, 25.3), (40.0,23.6), (50.0,21.8), (60.0, 20.3),
(70.0, 18.4), (80.0, 16.8), (90.0, 14.9), (100, 12.3)

Chemical and Scaling Parameters
Parameters
AirJPPM = 300
DOCUMENT: This value is the concentration of a particular chemical exposure in parts
per million (PPM).
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BW = 40
DOCUMENT: The bodyweight of the individual used in the simulation of this model.
Chemical_MW=131.40
DOCUMENT: Molecular Weight of Trichloroethylene
Exposure = Air_PPM-STEP(Air_PPM,4)
DOCUMENT: The step function used in this parameter defines the length of exposure to
the chemical concentration in the air. In this case the individual is exposed to the Air
PPM for four hours.
LKm=1.5
DOCUMENT: Liver Km - Michaelis constant (mg/L). This was based on
'Pharmacokinetic Modeling of Trichloroethylene and Trichloroacetic Acid in Humans' by
Allen and Fisher (1993). The Vmax value for the liver can now be computed for any
bodyweight.
LVmax=14.9*(BWA7)
DOCUMENT: The scaling parameter of 14.9 was used to scale the Liver Vmax (mg/hr)
- maximum rate of enzymatic (saturable) metabolism. This was based on
'Pharmacokinetic Modeling of Trichloroethylene and Trichloroacetic Acid in Humans' by
Allen and Fisher (1993). The Vmax value for the liver can now be computed for any
bodyweight.
PB = 7
DOCUMENT: Brain-Blood Partition Coefficient
This value is a realistic assumption at this time. A richly perfused-blood partition
coefficient of 6.8 has been used in previous PBPK models (Allen and Fisher-1993). The
brain compartment was included in the richly perfused compartment in these previous
models, so when the brain is separated into it's own compartment the partition coefficient
should be fairly similar.
PBB=1
DOCUMENT: BrainBlood-Blood Partition Coefficient
Assumption - Blood-Brain Barrier Compartment is an aqueous concentration
(intracellular fluid) so this value will equal 1.
PBloodAir = 9.2
DOCUMENT: Blood-Air Partition Coefficient
Found in - Pharmacokinetic Modeling of Trichloroethylene and Trichloroacetic Acid in
Humans' by Allen and Fisher (1993)
PF = 73.3
DOCUMENT: Fat-Blood Partition Coefficient
Found in - Pharmacokinetic Modeling of Trichloroethylene and Trichloroacetic Acid in
Humans' by Allen and Fisher (1993)
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PL = 6.8
DOCUMENT: Liver-Blood Partition Coefficient
Found in - Pharmacokinetic Modeling of Trichloroethylene and Trichloroacetic Acid in
Humans' by Allen and Fisher (1993)
PR = 6.8
DOCUMENT: Richly Perfused-Blood Partition Coefficient
Found in - Pharmacokinetic Modeling of Trichloroethylene and Trichloroacetic Acid in
Humans' by Allen and Fisher (1993)
PS = 2.3
DOCUMENT: Slowly Perfused-Blood Partition Coefficient
Found in - Pharmacokinetic Modeling of Trichloroethylene and Trichloroacetic Acid in
Humans'by Allen and Fisher (1993)

Fat Tissue Compartment
Stock
Fat_Tissue(t) = Fat_Tissue(t - dt) + (Fatjnflow - FatVein_Outflow) * dt
INIT Fat_Tissue = 0
DOCUMENT: This stock represents the accumulation point in the fat tissue where
arterial blood flow enters and venous blood flow exits.
Inflow
Fat_Inflow = Arterial_Blood_Conc*QF
DOCUMENT: The fraction of the arterial blood flow which enters the fat tissue
compartment.
Outflow
FatVein_Outflow = QF*Fat_Conc/PF
DOCUMENT: This represents the fraction of venous blood flow which exits the fat
tissue.
Parameters
Fat_Conc = Fat_Tissue/Fat_Vol
DOCUMENT: This connector represents the concentration of chemical in the fat stock
or tissue.
Fat_Vol = .19*BW
DOCUMENT: The fat volume is scaled so that any bodyweight can be used to find the
behavior of chemical concentrations in a particular sized individual.
Value of .19 found in - Pharmacokinetic Modeling of Trichloroethylene and
Trichloroacetic Acid in Humans' by Allen and Fisher (1993)
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Fractional Distributions
Parameters
FB = IF(Exercise=0)THEN(.12)ELSE(.12)
DOCUMENT: This is the fractional distribution of the blood flow rate to the brain tissue
compartment. The distributions to the different tissues will change with the addition of
stress or exercise. 'Physiological Parameter Values for PBPK Models' (December 1994) Value found on page 51 (the human brain receives about 12% of the cardiac output in the
human body and Distribution does not change during exercise)
Resting Individual = 12%
Exercise = 12%
FF = IF(Exercise=0)THEN(.05)ELSE(.03)
DOCUMENT: This is the fractional distribution of the blood flow rate to the fat tissue
compartment. The distributions to the different tissues will change with the addition of
stress or exercise.
'Pharmacokinetic Modeling of Trichloroethylene and Trichloroacetic Acid in Humans' by
Allen and Fisher (1993) - Resting value
'Human Circulation Regulation During Physical Stress' by Rowell (1986) - Exercise
value found on page 235 (Distribution decreases by 40% during exercise)
Resting Individual = 5%
Exercise = 3%
FL = IF(Exercise=0)THEN(.26)ELSE(.13)
DOCUMENT: This is the fractional distribution of the blood flow rate to the liver tissue
compartment. The distributions to the different tissues will change with the addition of
stress or exercise.
'Pharmacokinetic Modeling of Trichloroethylene and Trichloroacetic Acid in Humans' by
Allen and Fisher (1993) - Resting value
'Human Circulation Regulation During Physical Stress' by Rowell (1986) - Exercise
value found on page 240 (Distribution decreases by 50% during exercise)
Resting Individual = 26%
Exercise = 13%
FR = IF(Exercise=0)THEN(.32)ELSE(.32)
DOCUMENT: This is the fractional distribution of the blood flow rate to the richly
perfused tissue compartment. The distributions to the different tissues will change with
the addition of stress or exercise.
'Pharmacokinetic Modeling of Trichloroethylene and Trichloroacetic Acid in Humans' by
Allen and Fisher (1993) - Resting value
'Human Circulation Regulation During Physical Stress' by Rowell (1986) - Exercise
value on page 240 (Distribution does not change during exercise)
Resting Individual = 32%
Exercise = 32%
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FS = IF(Exercise=0)THEN(.25)ELSE(.40)
DOCUMENT: This is the fractional distribution of the blood flow rate to the slowly
perfused tissue compartment. The distributions to the different tissues will change with
the addition of stress or exercise.
'Pharmacokinetic Modeling of Trichloroethylene and Trichloroacetic Acid in Humans' by
Allen and Fisher (1993) - Resting value
'Human Circulation Regulation During Physical Stress' by Rowell (1986) - Distribution
increases by 62.5% during exercise
Resting Individual = 25%
Exercise = 40%
QB = FB*QC
DOCUMENT: Blood flow to the brain tissue group. This is calculated by multiplying
the total cardiac output by the particular fraction to each tissue.
QF = FF*QC
DOCUMENT: Blood flow rate to the fat tissue group. This is calculated by multiplying
the total cardiac output by the particular fraction to each tissue.
QL = FL*QC
DOCUMENT: Blood flow to the liver tissue group. This is calculated by multiplying
the total cardiac output by the particular fraction to each tissue.
QR = FR*QC
DOCUMENT: Blood flow to the richly perfused tissue group. This is calculated by
multiplying the total cardiac output by the particular fraction to each tissue.
QS = FS*QC
DOCUMENT: Blood flow rate to the slowly perfused tissue group. This is calculated
by multiplying the total cardiac output by the particular fraction to each tissue.

Liver (Metabolizing) Tissue Compartment
Stock
Liver_Tissue(t) = Liver_Tissue(t - dt) + (Liver_Inflow - LiverVein_Outflow Liverjvletabolism) * dt
INIT Liver_Tissue = 0
DOCUMENT: This stock represents the accumulation point in the liver tissue where
arterial blood flow enters and venous blood flow exits.
Inflow
Liver_Inflow = Arterial_Blood_Conc*QL
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DOCUMENT: The fraction of the arterial blood flow that enters the liver tissue
compartment.
Outflow
LiverVein_Outflow = QL*Liver_Conc/PL
DOCUMENT: This represents the fraction of venous blood flow that exits the liver
tissue.
Parameters
Liver_Metabolism = (LVmax*Liver_Conc/PL)/(LKm+Liver_Conc/PL)
DOCUMENT: Metabolism was assumed to occur in the liver tissue for this particular
model. The saturable metabolic transformation of any particular chemical in the liver
was defined using the Michaelis-Menten equation with the bio-chemical constants Vmax
and Km.
Liver_Conc = Liver_Tissue/VL
DOCUMENT: This connector represents the concentration of chemical in the liver stock
or tissue.
VL = .026*BW
DOCUMENT: The liver volume is scaled so that any bodyweight can be used to find the
behavior of chemical concentrations in a particular sized individual. Value of .026 found
in - Pharmacokinetic Modeling of Trichloroethylene and Trichloroacetic Acid in
Humans' by Allen and Fisher (1993)

Richly Perfused Tissue Compartment (Kidneys)
Stock
Rich_Tissue(t) = Rich_Tissue(t - dt) + (Richjnflow - RichVein_Outflow) * dt
INIT RichJTissue = 0
DOCUMENT: This stock represents the accumulation point in the richly perfused tissue
where arterial blood flow enters and venous blood flow exits.
Inflow
Richjnflow = Arterial_Blood_Conc*QR
DOCUMENT: The fraction of the arterial blood flow that enters the richly perfused
tissue compartment.
Outflow
RichVein_Outflow = QR*Rich_Conc/PR
DOCUMENT: This represents the fraction of venous blood flow that exits the richly
perfused tissue.
Parameters
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Rich_Conc = Rich_Tissue/VR
DOCUMENT: This connector represents the concentration of chemical in the richly
perfused stock or tissue.
VR = (.05*BW)-VBT
DOCUMENT: The richly perfused volume is scaled so that any bodyweight can be used
to find the behavior of chemical concentrations in a particular sized individual. The brain
tissue compartment volume is also subtracted from this value since the brain is a separate
compartment in this model and should not be included in the richly perfused volume.
Value of .05 found in - Pharmacokinetic Modeling of Trichloroethylene and
Trichloroacetic Acid in Humans' by Allen and Fisher (1993)

Slowly Perfused Tissue Compartment (Skin, Muscle)
Stock
Slow_Tissue(t) = Slow_Tissue(t - dt) + (Slowjtnfiow - SlowVein_Outflow) * dt
INIT Slow_Tissue = 0
DOCUMENT: This stock represents the accumulation point in the slowly perfused tissue
where arterial blood flow enters and venous blood flow exits.
Inflow
Slow_Inflow = Arterial_Blood_Conc*QS
DOCUMENT: The fraction of the arterial blood flow which enters the slowly perfused
tissue compartment.
Outflow
SlowVein_Outflow = QS*Slow_Conc/PS
DOCUMENT: This represents the fraction of venous blood flow which exits the slowly
perfused tissue.
Parameters
Slow_Conc = Slow_Tissue/VS
DOCUMENT: This connector represents the concentration of chemical in the slowly
perfused stock or tissue.
VS = .62*BW
DOCUMENT: The slowly perfused volume is scaled so that any bodyweight can be used
to find the behavior of chemical concentrations in a particular sized individual. Value of
.62 found in - Pharmacokinetic Modeling of Trichloroethylene and Trichloroacetic Acid
in Humans' by Allen and Fisher (1993)
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Appendix C - Model Testing
Initial Testing:
Comparative graphs of the tissue concentrations at rest (#1) and at heavy exercise (#2)
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Figure 36. Brain Blood Concentration (1-Rest, 2-Heavy Exercise)
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Figure 37. Brain Tissue Concentration (1-Rest, 2-Heavy Exercise)
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Figure 38. Liver Concentration (1-Rest, 2-Heavy Exercise)
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Figure 39. Richly Perfused Concentration (1-Rest, 2-Heavy Exercise)
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Figure 40. Slowly Perfused Concentration (1-Rest, 2-Heavy Exercise)
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Exercise Testing:
Comparative Graphs for the varyinfi tissue concentrations at the 5 Levels of Exercise:
1 Rest
1 - Moderate Exercise (15%)
2- Heavy Exercise (25%)
3- Strenuous Exercise (55%)
4- Maximum Output (100%)
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Figure 41. BBB Concentrations at 5 Levels of Exercise
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Figure 42. Brain Blood Concentrations at 5 Levels of Exercise
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Figure 43. Brain Tissue Concentrations at 5 Levels of Exercise
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Figure 44. Liver Concentrations at 5 Levels of Exercise
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Figure 45. Richly Perfused Concentrations at 5 Levels of Exercise
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Figure 46. Slowly Perfused Concentrations at 5 Levels of Exercise
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Bodyweight Testing:
Sensitivity Analysis of Bodvweight and Effect on Tissue Concentrations CRanee = 60110 kg)
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Figure 47. BBB Concentrations for Increasing Levels of Bodyweight.
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Figure 48. Brain Blood Concentrations for Increasing Levels of Bodyweight.
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Figure 49. Brain Tissue Concentrations for Increasing Levels of Bodyweight.
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Figure 50. Liver Concentrations for Increasing Levels of Bodyweight.
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Figure 51. Richly Perfused Concentrations for Increasing Levels of Bodyweight.
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Figure 52. Slowly Perfused Concentrations for Increasing Levels of Bodyweight.
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Parameter Testing:
Sensitivity Analysis of the Brain Tissue/Blood Partition Coefficient (Values = 2. 6.5. 11.
15, and 20)
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Figure 53. BBB Concentrations for Increasing Values of the Brain/Blood PC
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Figure 54. Brain Blood Concentrations for Increasing Values of the Brain/Blood PC
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Figure 55. Brain Tissue Concentrations for Increasing Values of the Brain/Blood PC

Sensitivity Analysis of the Transfer Rate fRanee = 2. 7.75.13.5. 19.3. and 251
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Figure 56. BBB Concentrations for Increasing Values of the Transfer Rate
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Figure 57. Brain Blood Concentrations for Increasing Values of the Transfer Rate
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Figure 58. Brain Tissue Concentrations for Increasing Values of the Transfer Rate
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Sensitivity Analysis of the Brain Km (Range = .5. 1.13.1.75.2.38. 3)
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Figure 59. BBB Concentrations for Increasing Values of the Brain Km
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Figure 60. Brain Blood Concentrations for Increasing Values of the Brain Km
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Figure 61. Brain Tissue Concentrations for Increasing Values of the Brain Km

Sensitivity Analysis of the effects of Transfer Rate CRange = 2-25~) on Passive Diffusion
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Figure 62. The Effects of Increasing Transfer Rates on Passive Diffusion
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Sensitivity Analysis of the effects of increasing exercise on Passive Diffusion (110 kg)
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Figure 63. The Effects of Increasing Exercise Levels on Passive Diffusion
Sensitivity Analysis of the effects of the 5 levels of exercise on Brain Vmax, which then
affects the overall behavior of Metabolism from the blood-brain barrier for 110 kg.
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Figure 64. The Effects of Increasing Exercise Levels on Metabolism
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Sensitivity Analysis of the effects of increasing exercise on Maximum Transport, which
then affects the overall behavior of Mediated Transport between the brain blood
compartment and the blood-brain barrier for 110 kg.
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Figure 65. The Effects of Increasing Exercise Levels on Mediated Transport
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Extreme Conditions:
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Figure 66. Brain Concentrations at a Minimum Bodyweight of 40 kg
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Figure 67. Brain Concentrations at a Maximum Exposure of 300 ppm
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